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A polyacrylonitrile (PAN) membrane (Cobe Laboratories, 
Inc., Lakewood, Colorado) has been under investigation for use 
in artificial kidney devices. Since this new membrane is sig­
nificantly different from current hemodialysis membranes of 
cellulose, this investigation was undertaken to study the 
effects of different biologically significant materials on the 
fluid transfer (ultrafiltration r a t e —  UFR) and mass transfer 
resistance (RQ ) of creatinine and vitamin B ^  of* the PAN mem­
brane .
The expense of present hemodialysis remains quite high, 
and therefore, reuse of artificial kidneys can reduce consid­
erably the cost of hemodialysis. Therefore, the effects of 
various cleansing agents and techniques were evaluated for 
potential artificial kidney reuse.
The biological compounds tested in this investigation 
included human blood, albumin, hemoglobin, deoxyribonucleic 
acid (DNA) and dextran (M.W. = 66,900). The cleansing pro­
cedures included hypochlorite, peroxide and reverse pressure 
treatments.
The tests were performed on PAN hollow fibers provided 
by Cobe Laboratories, Inc., in the form of bundles containing 
150 fibers (about 1/80 the size of present day artificial 
kidneys).
The static ultrafiltration coefficient (static UFR) was 
determined from the ultrafiltration rate measured at a fixed
iii
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transmembrane pressure and under the condition of no bulk flow 
in the blood side phase.
Mass transfer coefficients were evaluated by using the 
dual single pass method and the well mixed dialysate flow 
geometry. The overall mass transfer resistance (RQ) was cal­
culated from the concentration changes measured by optical
14density (vitamin B ^ )  and radioactivity (C -creatinine).
Data from twelve (12) bundles yielded a range of static
UFRfs from 2.02 to 3.22 ml/hr/mmHg/m before blood treatment
oand Q.72 to 1.3^ ml/hr/mmHg/m after blood treatment. The Rq
of vitamin for 11 bundles ranges from 317.0 to 677.8 min/
cm before and 436.2 to 1177.7 mirt/cm after blood treatment.
The R of creatinine for 12 bundles ranges from 74.2 to 186.3 o
min/cm before and 107.0 to 178.8 min/cm after blood treatment.
On the basis of a t distribution analysis (90% confidence 
level for biochemical treatments, 95# confidence level for 
reuse chemicals and treatments), there are the following mem­
brane effects:
- e
1. All the reductions in the static UFR and the increases
in R for vitamin B, 0 and creatinine are significant —  blood,Q Id
hemoglobin, albumin and sodium hypochlorite treatment.
2. The reductions of the static UFR and the increases in
Rq of vitamin B ^  are significant, but there are no signifi­
cant changes in the Rq of creatinine —  DNA and dextran 
(M.W. * 66,900).
3. The reductions of the static UFR are significant but
iv
T 1765
there are no significant changes of the Rq of vitamin and 
creatinine —  hydrogen peroxide treatment alone.
4. No significant changes of the static UFR or the Rq of 
vitamin an^ creatinine —  hydrogen peroxide and reverse 
pressure treatments after blood treatment.
These findings show that the significant reductions in 
UFR and solute permeability by blood contact will greatly 
affect the efficiency of PAN membrane dialyzers and must be 
considered in the final dialyzer design. The current reuse 
techniques will not recover the original membrane permeabil­
ity characteristics of the PAN membrane, and, in some cases, 
could further reduce permeability; therefore, these tech­
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2A = area, cm
A * cross section area of a spherical molecule,
Â . = total transmembrane area, cm^
C = concentration or total concentration,
moles/cm3
Cg = blood concentration, moles/cm3
Cg^ = concentration of blood-in, moles/cm^
CgQ = concentration of blood-out, moles/cmJ
Cg = blood concentration at time zero, moles/cm3
Cg * dialysate concentration, moles/cm
Cg^ 6 = concentration of dialysate-in, moles/cmJ
oCn = concentration of dialysate-out, moles/cmDo
,0
'DC° = dialysate concentration at time zero, moles/cmJ
(C)^ & = bulk concentration in blood phase and dialy­
sate phase, moles/cm3
(Cg - Cg)Q = concentration difference between blood and
dialysate at time zero, moles/cm3
(Crj - Cr\) * = concentration difference between blood ando u u odialysate at time t, moles/cm0
C r & C" = concentration at ends of a membrane, moles/
cm3
oC# = clearance, cmJ/min
CTr = g-mole of water/ml of solutionw




A C  = mean molar concentration, moles/cm^osm
D = diffusion coefficient (diffusivity), cm2/sec
or cm2/min
2= effective diffusivity, cm /sec
= binary diffusivity for interdiffusion of 
molecules species 1 and 2, cm^/sec
oD12 = diffusivity of solute at infinite dilution,
cm^/sec
Dg = blood dialysance, cm^/min
d = diameter of hollow fiber, m
= force acting on species 1, dyne 
J* = diffusive mole flux, moles/min/cm
c*
j = species, dimensionless
2j* = diffusive mass flux, gm/min/cm
K = mass transfer coefficient, cm/min
Kg = mass transfer coefficient of blood film,
cm/min
Kn = mass transfer coefficient of dialysate film,
cm/min
Kq = overall mass transfer coefficient, cm/min
k = Boltzmann constant, gm cm/sec /k
Le = effective length of hollow fiber, m
1+° & 1-° = cationic and anionic conductance at infinite
dilution, mhos/equivalent
M = total moles of solute, moles
M * molecular weight of solvent, gm/molew
Mq = molecular weight of solute, gm/mole
m = molality, moles of solute/1000 g solvent
M or N = mass transfer rate, moles/min
xiv
T 1765
= total number of hollow fibers, dimensionless
2N = mole flux, moles/min/cm
N^e = Reynolds number, dimensionless
n^ = Nernst partition coefficient, dimensionless
P = pressure, mmHg
= pressure of blood-in, mmHg
Pgo = pressure of blood-out, mmHg
Pp^ = pressure of dialysate-in, mmHg
PDo = pressure of dlalysate-out, mmHg
PM = membrane permeability, cm/mln
(Pj)^ = membrane permeability for species j, cm/mln
A P m  = hydrostatic transmembrane pressure gradient,
11 mmHg
A  Posm = osmo^̂ -c transmembrane pressure gradient, mmHg
Q = volumetric flow rate, cm/min
Qg = blood flow rate, cm/min
oQg^ = flow rate of blood-in, cm'Vmin
= flow rate of blood-out, cm'VminDO oQDi = flow rate of dialysate-ln, cm/mln
Qgo = flow rate of dlalysate-out, cm/min
Rg = resistance of blood film, min/cm
Rg = resistance of dialysate film, min/cm
R^ = resistance•of membrane, min/cm
R° = effective membrane resistance at T-* °°, min/cm
R = overall mass transfer resistance, min/cmo 5
(Rj)^ 55 membrane resistance for species j




r2 = radius of the spherical molecule, A
T = absolute temperature, °K
t * time for closed loop dialysis, min
“3U = ultrafiltration rate, cm'Vmin
UQ = overall ultrafiltration rate, cm/min
•3= hydrostatic ultrafiltration rate, cm/min 
tJ w * osmotic ultrafiltration rate, cm /min
usc = static ultrafiltration coefficient, cm /mmHg/
hr/m or cm3/mmHg/min/m^
QV = static ultrafiltration volume, cmJ
•3Vg = closed loop blood volume, cmJ
■?Vg = closed loop dialysate volume, cm
VQ = molar volume of solute at normal boiling
point, ml/g-mole
v = velocity, cm/min
v* = molar average velocity, cm/min
X = association parameter, dimensionless
x = distance of diffusion path, cm
x^ = variable associated with the 1, 2, 3 axes,
dimens ionise s s
Ax = membrane thickness, cm
y^ = mole fraction of species 1, dimensionless
= coefficient of sliding friction, dimensionless
a f - reflection coefficient, mmHg cm/moles
= unit vector, dimensionless
U = viscosity, cp
u = viscosity of water, cpw
p = mass concentration, g/cm
xvi
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= the "del" or "nabla" operator
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The kidney is a very important organ In the human body.
It plays a prominent role in keeping the balance of our
internal fluid in equilibrium. The artificial kidney system 
or kidney transplantation may be used in renal failure. The 
membrance effects and materials are very important items for 
researchers in the field of artificial kidney systems.
A. Functions, Mechanisms and Structure of the Human Kidney 
The kidney performs many functions and mechanisms by. 
its special structure and the functional unit, the nephron.
* 1. Functions of the human kidney: The human kidney
controls the concentration of solutes in the plasma and
©
excretes the unwanted exogeneous substances and waste 
metabolites. Their functions can be represented as follows 
(1,2):
a. Water balance: The kidney of a typical adult
excretes about 50 ml urine per hour in normal 
activity. If one drinks or loses too much water 
in a short period of time, his kidneys elimin­
ate or conserve the water by changing the amount 
of urine being released.
b. Electrolyte balance: In spite of different intakes
and metabolic procedures, the kidney excretes a
T 1765 2
suitable amount of inorganic salts for keeping 
the osmotic pressure constant and the balance 
of the concentration of potassium, sodium, cal­
cium and other ions in the plasma.
c. Acid-base balance: The respiratory system and the
kidneys maintain an acid-base balance in the body 
fluids. The concentration of chloride, bicarbon­
ate ions and the pH value of the plasma are kept 
constant and are regulated by the respiration 
system and the kidneys. Any large variation will 
induce responses of these excretion systems.
Their responses will keep the acid-base balance 
in the human body. The kidney’s functions are 
as follows:
i. It excretes some excess acid or base directly.
ii. It produces ammonia (NH^) to neutralize the 
excess acid.
ill. It changes the concentration ratio of acid 
to basic phosphate ([NaH^PO^l/CNa^HPO^]) in 
the urine.
d. Waste excretion: The kidney excretes the end
products of metabolism, such as urea, uric acid 
and creatinine.
e. Detoxification: The kidney detoxifies certain
organic compounds, such as benzoic acid, dye or 
inulin, by releasing these compounds into the 
urine.
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f. Hormone and enzyme synthesis: The kidneys are the
• major control system for red blood cell produc­
tion by hormone synthesis (erythroprotein). The 
enzyme (renin) produced in the kidney has the 
function to control the extra-cellular blood vol­
ume .
2. The Structure of the Kidney (3»4): The kidney can
be considered as containing two parts. The outer portion, 
the cortex, is reddish-brown in color and has a granular 
appearance. The inner portion, the medulla, is reddish- 
brown to gray-brown in color and contains some fan-like 
striations which are called renal pyramids. Figure 1 (3) 
shows the coronal section of the kidney. The urine flows 
from the papillary ducts of the pyramids into the calyces 
leading to the renal pelvis, From the pelvis, urine flows 
into the ureter which leads to the urinary bladder. Figure 
2 (4) shows the renal circulation. The arteries in a kidney 
include the renal artery, the interlobar artery, the arci- 
form artery and the interlobular artery. Blood vessels 
entering and leaving the Brownian's capsule are shown in Fig­
ure 3 (5), which shows the union of nephron with a collect­
ing tubule. The blood vessels that surround the convoluted 
tubule form networks which then are connected to the arcuate 
veins. At this point, the veins follow the same general 















Figure 1. Coronal section of the kidney 
From : Pitts, R. F,, : " Physiology of the kidney and
















Figure 2. Cross morphology of the renal circulation.
From : Pitts, R. F. , : "Physiology of the kidney and body 
fluids’1, 1963, p. 12.
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3• The nephron and Its mechanisms of urine production: 
The nephron consists of the glomerulus, the Brownian’s cap­
sule and a long curved convoluted tubule. The convoluted 
tubule includes the proximal and the distal convoluted tub­
ule, and the descending and ascending limbs of loop of Henle. 
The different parts of the nephron are shown in Figure 3 and 
are involved in the different mechanisms for urine produc­
tion (6,7*8).
a. Glomerular filtration: Substances having molecular
weights lower than 6800 can be filtered from the 
semi-permeable membranes in the glomeruli.
The driving forces of filtration are the dif­
ferential pressure and concentration gradient 
between glomerular capillary loops and their en­
vironment in the Brownian’s capsule. Approximately 
500 ml blood enters each kidney each minute and 
120 to 130 ml of fluid is filtered through the 
membranes of the glomeruli.
b. Tubular reabsorption: Most of the filtered fluid
is reabsorbed in the convoluted tubule and only 
about 1 ml per minute is excreted in the urine 
from each kidney. This is the principal 
mechanism for concentrating urine. Some sub-
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stances, such as amino acids, vitamins, and 
glucose, having renal thresholds which have been 
defined as the concentration present in the blood 
before its excretion by the kidney. Substances 
having concentrations lower than their renal 
threshold in the blood will be completely reab­
sorbed by the tubule cell, otherwise the excess 
substances will be eliminated. By expenditure of 
energy and the presence of some enzymes, the tubu­
lar cell can transport substances against the 
direction of concentration gradient, which is 
called active transport. Water and useful com­
pounds are removed from the tubular fluid and are 
returned to the blood through the peritubular 
capillaries by means of the active transport, in 
addition to osmosis and diffusion,
c. Tubular secretion: Hydrogen ions (H+ ) are secreted
e
by the tubule cell in exchange for sodium ions 
(Na+ ) which combine with bicarbonate ions (HCO^) 
and are returned to the blood for maintaining 
the base balance. Ammonia (NH^) is formed by the 
tubule cell and secreted as ammonium salt for pre­
serving the sodium ions (Na+ ) and maintaining the 
base balance. Active secretion of K by the 
distal tubule cells not only serves to eliminate 
excess K but is an important way to save Na .
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The kidney increases or decreases the acidity of 
the urine and regulates the acid-base balance of 
the body by means of secreting varying amounts of 
hydrogen ions, potassium ions and ammonia,
d. Tubular excretion: Foreign substances (such as
penicillin and certain dyes) and waste materials 
(such as creatinine) are excreted by the tubule 
cell using the mechanism of active transport.
B. Renal Disease (9)
The destruction of the nephron will decrease the abil­
ity of the kidney to perform its function. From a medical 
, viewpoint, the kidney diseases can be classified as follows: 
Nephritis is a bilaterial inflammatory disease of 
the kidney. If the glomerular capillaries and the tubules 
are destroyed by antigen-antibody reaction, the disease is 
called glomerulonephritis. In acute cases, the kidney 
ceases its functions within several weeks. In chronic cases, 
the renal destruction continues for a long period of time.
The glomerular damage causes the kidney to lose its func­
tion of ultrafiltration. When one is affected by these 
diseases, proteins appear in the patient’s urine and the 
nitrogen concentration increase in his blood. If the medulla 
portion of the kidney is infected by bacteria, the disease 
is called pylonephritis. The tubules are destroyed and lose 
their function. Excessive urine and excretion of increased
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amounts of inorganic salt usually occur in cases where people 
are afflicted with pylonephriti?.
2. Nephrosis is the bilateral degenerative disease of 
the kidney. The kidney is denatured by different causes. 
Lipoid nephrosis occurs when large amounts of lipid are 
generated by an individual’s metabolism and its primary 
leision is glomeruli. Except for the increased amount of 
lipid in the blood, the patient shows the same symptoms as 
those patients who are afflicted with the chronic glomeru­
lonephritis. Tubular necrosis is the local change of the 
renal tubular epithelium and is induced by chemicals, bac­
terial toxin, deficiency of blood or the absence of oxygen. 
The main symptoms of nephrosis are the diminution of urine 
and the development of uremia which is the accumulation in 
the blood of substances ordinarily eliminated in the urine.
3. Nephrosclerosis is the disease of hardening of the 
kidney and is characterized by thickening of arterioles, 
degeneration of renal tubules and thickening of glomeruli. 
Patients show the effects of hypertension and uremia.
4. Toxemia of pregnancy may be induced by an antigen- 
antibody reaction and its primary lesion is glomeruli.
The renal blood flow rate and the ultrafiltration rate have 
decreased in this disease. The main symptoms are proteins 
appearing in patients’ urine and edema which is the abnormal 
accumulation of fluid in the patient's body.
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5. Congenital disorders are structural malformation 
of glomeruli and tubules or an Inborn defect of tubular 
transport. Reducing glomerular filtration rate and/or 
tubular transport capacity, the patients show uremia (and 
edema in some cases).
C. Hemodialysis
The functions of the kidney may be reinstated by medi­
cation only in early stages of chronic renal failure. If 
the medication does not totally recover the renal functions, 
the patient has the choice between renal transplantation 
and hemodialysis. The latter means a process of the removal 
of boxins and water by an artificial kidney which is known
as the hemodialyzer or dialyzer. The objectives of the hemo
©
dialyzer can be represented as in Figure 4.
Flow in the blood side and salt solution in the dialy- 
sate side are kept in separate compartments. A semi-
e
permeable membrane, which is between the blood flow and the 
dialysate flow in a hemodialyzer, may be thought of as a 
filter (see figure 5 (10)). Plasma proteins and substances 
highly bound to proteins are not diffusible through the mem­
brane, but the low or middle molecular weight compounds can 
diffuse from the higher concentration side through the mem­




Figure $• The surface of an idealised porous 
membrane having pores of three di­
fferent diameters occupying di­
fferent fractions of the total 
surface.
From: Keller Kenneth H. 11 Fluid Mechanics
and Mass Transfer in Artificial Organs11 
A3AI0 19th Annual Meeting. Boston,
April 7, V?73, p. 83.
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The overall mass transfer permeability Is dependent on 
the thickness, the pore diameter, the total area of the 
membrane, the flow rate and the concentration gradient 
between the two sides. In the hemodialyzer, both the blood 
side and the dialysate are continuous flow.
The flow geometry may be cocurrent flow, counter- 
current flow, well mixed dialysate or cross flow. The blood 
rate is maintained in the range of 100 to 300 ml/min and the 
dialysate solution flows at a rate of 200 to 500 ml/min.
Low flow rates are normally in priming of the hemodialyzer 
and for the return of blood. The temperature is kept at 
98 t 1°F in hemodialysis. The patient usually is in hemo­
dialysis 2 to 3 times a week and 4 to 7 hours per run. A 
typical hemodialysis system is illustrated by the sketch 
shown in Figure 6 (11).
1. Comparison between the human kidney and the arti­
ficial kidney system: Different mechanisms cause different
cfunctions. Their comparison in the mechanisms and functions 
are represented as follows:
a. Mechanisms: The kidney has four mechanisms which
are glomerular filtration, tubular reab­
sorption, tubular secretion and tubular excre­
tion. But a hemodialyzer only has the mechanism' 
of ultrafiltration.
In the human kidney, blood contents having 
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can be ultrafiltered through the glomerular mem- 
• brane and the useful compounds are reabsorbed by 
the tubular cell. In a hemodialyzer, only the 
^small or middle molecular weight substances can 
be passed through the membrane and the useful 
materials are kept from being removed by elec­
trolytic balance,
b. Functions: In the six functions of the human kidney,
the hemodialyzer can simulate only the four func­
tions of water balance, electrolyte balance, waste 
excretion and detoxification.
The hemodialyzer excretes excess acid or base 
but it cannot produce ammonia or change the con­
centration ratio of acid to basic phosphate.
Besides this, the hemodialyzer cannot synthesize 
any hormone or enzyme but the human kidney gener­
ates erythroprotein and renin.
2. Types of hemodialyzers: The first significant clin­
ical use of an artificial kidney system was reported by 
Kolff and Berk in 1 9 ^  (12). An cellophane-tube, 25 mm wide 
and 25 to 30 meters long (area about 1.7 to 2.3 m ), was 
spirally wound around a cylinder, with the lowest point 
placed in a bath of 70 liters of dialysate.
There were two methods of dialysis in this clinical use.
xIn fractionated dialysis, the blood circulates a few times
*This special technique Is not used now. The detailed des­
cription was reported in reference 12.
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through the artificial kidney and 24, 40 and 85 grams of 
urea could be dialyzed out in 1.5, 4 and 6 hours, respec­
tively. In continuous dialysis* the blood flows only one 
time through the dialyzer and therefore the waste materials 
didn't wash out so completely.
There have been many improvements made in the artific­
ial kidney system during the last thirty years.
a. All dialysis are of the continuous flow type 
and the blood circulates 4 to 7 hours through 
the hemodialyzer.
b. All of the membranes are surrounded with dialy­
sate solution and the waste materials can be 
transported from whole membranes in the same time.
c. High dialysate flow rates are chosen for reduc­
ing the mass transfer resistance on the dialysate 
side.
d. Monitors and controls are added to check and
o
regulate the patientTs conditions in hemodialysis.
e. For getting minimal size and better mass transfer 
effect, three different types of hemodialyzers 
are in present use (13)*
i. Plate type: The hemodialyzer is composed of
many flat sheets of membrane clamped between 
ridged plates. Blood flows in several chan­
nels between the membrane sheets. Dialysate
*In this dialysis, the blood flows through the tube continu­
ously, but the mass transfer only occurs in those parts sub 
merged inside the dialysate bath.
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solution flows In the grooves between sheets 
and plates (see Figures 7.a and 8).
11. Coll type: The coll Is wound around a cylin­
drical core and supported by fiberglass 
sheets. There are two or four tubes con­
nected to the coll (see Figure 7.c and 9).
The dialysate solution flows from the reser­
voir into the container and then overflows 
the top.
iii. Hollow fiber type: Instead of one tube, many
hollow fibers are placed in a plastic container
(see figure 10). Both ends are potted with 
resin for separating the blood side and the 
dialysate side (see figure 11). The number of 
fibers, inside diameter and effective length 
determine the total membrane area and blood 
volume in this type of hemodialyzer. Figure 12 
shows a special design for cross flow geometry. 
Figure 13 presents two designs in Cobe PAN 
hemodialyzer and Dow hemodialyzer for high 
dialysate flow rate.
3. Parameters for evaluation of a hemodialyzer are:
a. Blood volume is the total volume in the blood side
of hemodialyzer.
b. Clearance is defined as the removal rate of a solute
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Keller Kenneth H. , !iPluid 
Mechanics and :*iass trans­
fer in artificial Organs" 
ASAIO 19th annual Meeting. 
Boston, April 7, 1973 
p. 56.
DIALYZATE FLOW
^c). Coil flat tube pseudo-parallel plate flow.
Figure 7. different Types of Hemodialyzer —  idealized repre­
sentation of three kinds of dialyzers indicating 




I'll III ' " H
Plat
 ______ Dlalvsate _______ _um m i n i m u m  l u n m
4-
Bloodi i r j r i n i i i imnmni rn
Dialysate
f i l l  1 1 1
Ridged / / Plate
/ 1 1 1  1 1 1 1 1 1




Figure 9. Extension of Coil-type dialyzer membrane
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Fiber number = 11000-13000, Le = 24 cm, A = 1.5 m .
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Figure 11. Tube Sheet of Cobe PAN Hollow Fiber Artificial Kidney
T 1765
Dialysate Solution In
1 .................... _ 1
^  i
I « ......-  * r  t  1
*  -  1
_r . i r  t  t  1




Figure 12. Special Design for Cross Flow Geometry 
( — ► : Dialysate flow direction)
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(b) Diagram of Cobe»s PAN Dialyzer ( side view ) 
Figure 1 3. Diagram of Design- for High Dialysate'Flow.
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concentration of the solute. It is represented 
by the volumetric rate at which blood is cleared 
of the solute.
c. Dialysance is defined as the removal rate of a
solute from the blood phase per unit concentra­
tion difference of the solute between incoming 
blood and incoming dialysate solution. Dialysance 
can be represented by the following equation
n = QBi CBi ~ QBo CBo
B CBi “ CDi
QDo CDo “ QDi CDi
CBi “ %  ( '
where
Dg = blood dialysance
Qb i ,Qbo = incoming and leaving blood flow rate
Qd i j Qdo = incoming and leaving dialysate flow rate
Cb i j Cbo = incoming and leaving blood concentration
CDijCDo = incominS and leaving dialysate concen­
tration
d. Mass transfer coefficient or permeability coefficient
is defined as the mass transfer rate per unit area 
per concentration difference of a solute between 
the blood side and the dialysate side.
e. Mass transfer resistance is defined as the recipro­
cal of mass transfer coefficient.
T 1765
f* Static ultrafiltration rate is defined as the 
removal volume rate from the blood phase per 
unit of pressure gradient on the basis of no 
bulk flow in the blood phase, 
g* Ultrafiltration rate has the same definition as 
the static ultrafiltration rate but having 
bulk flows in both sides.
4* Cost of hemodialysis: Different types of hemodialy­
sis show a large range of cost. Future hemodialysis will 
use the type of minimal cost for each treatment.
a* Different types of hemodialysis (dialysis) (14):
i. Institutional dialysis treatment: Running the 
dialysis in a hospital or an artificial kidney 
center is called "in-hospital dialysis" or "in-, 
center dialysis." Some dialysis units are 
affiliated with a large dialysis center. Run­
ning dialysis in an affiliated dialysis unit is 
called "affiliated dialysis" or "satellite 
dialysis." In these types of treatment, the 
patient stays in the hospital or one of the 
above centers and uses the facilities operated 
by the physician or paid staff.
ii. Self dialysis: After extensive training, the'
patient can do dialysis himself. The patient 
can run dialysis in his residence, which is 
known as home dialysis. There are some limita-
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ted care dialysis units where the space and 
equipment for self dialysis are provided but 
the patients have no significant professional 
supervision. Running dialysis In this type 
of treatment is known as "limited care dialy­
sis ."
b. Costs analysis: Cost for different types of hemo­
dialysis are listed in Table 1 (14), which is 
based on 3 times per week dialysis. The cost for 
institutional dialysis ranges from $10,140 to 
$52,000 per year per patient. In contrast, the 
average home dialysis cost for 78 patients in the 
state of Washington was $3,719 per patient for 
the year 1972. The average cost for affiliated 
(satellite) dialysis or limited care dialysis is 
between the two types of dialysis.
c. Future dialysis:
i. Home dialysis: From the costs analysis shown
in Table 1, home dialysis is much lower in cost 
than other types of dialysis. The great short­
age of money, manpower, and facilities in the 
field of health care may cause home dialysis 
to be considered more in the future. The 
institutional dialysis may be run only in case 
of acute dialysis, pre- and post-transplanta- 
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The artificial kidney system should be easy to 
operate in home dialysis. The Cobe Century II 
(see figure 14) is a typical treatment system 
which automatically controls and monitors the 
dialysis. Units such as this type will probably 
be used more often in home dialysis because of 
its ease of operation. Other problems, such as 
preparation time, cleaning and storing equip­
ment, space required for equipment and supplies, 
mechanical difficulties, and equipment failure, 
should be given consideration and worked out 
for future home dialysis,
ii. Dialyzer reuse: If reuse is possible, the cost
of dialysis for each treatment would be mini­
mized. Prom a survey of the most recent litera­
ture, a clear definition of an unreusable 
dialyzer has not been given. The percentage 
decrease of blood volume may be the easiest 
measurement to determine if the dialyzer can 
be reused again or not. Prom the viewpoint of 
the objectives of dialysis, the ultrafiltration 
rate and mass transfer permeability (mass trans­
fer coefficient, dialysance or cleance) is more 
significant than blood volume. ’’Reuse" should 
be defined clearly.before dialyzers are reused.
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Figure iH. Picture of Cobe Centry II —  Artificial Kidney 
System for Monitoring and Controlling Dialysis.
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5. Membrane materials: Materials for semi-permeable
membranes in hemodialysis have been researched since 1924.
The materials used in hemodialysis should be stable with 
respect to strength, durability and contain no toxicity.
There are many materials* which have been developed. Cello­
phane and cuprophane are presently being used commercially 
for the semi-permeable membranes in different dialyzers. 
Polyacrylonitrile (PAN) is a new membrane for dialysis and 
is being considered for future use.
D. Objectives of This Thesis
Polyacrylonitrile (PAN) hollow fibers are the membranes 
being investigated. The three objectives of this thesis are 
presented as follows:
1. Evaluation of the new membrane (PAN): Prom the
medical viewpoint, ultrafiltration rate and mass transfer 
permeability are the main parameters in evaluating a dialy­
zer. Static ultrafiltration coefficient and mass transfer 
coefficient (or resistance) are to be measured in this 
investigation for evaluation of PAN. Water, used for meas­
*Except for cellulose and cuprophane membranes, many differ­
ent materials are being investigated. These are poly­
acrylonitrile (PAN), viscose cellulose, poly (pyrrolidinone) 
(nylon 4), amylose, poly (hydroxyethl methacrylate) (HEMA), 
copolymers of hydroxypropyl methacrylate (HPMA), glycerol 
methacrylate (GMA), copolymer of HPMA, and 2-hydoxy-3- 
methacryloyl-oxypropyl trimethyl ammonium chloride (GMAC).
T 1765
uring static ultrafiltration coefficient, should remove ions 
and large organic molecules. In reverse osmosis, water 
containing dissolved materials is placed in contact with a 
suitable membrane (cellulose acetate membrane) at a pressure 
in excess of the osmotic pressure of the solution. After 
this treatment, the water is called RO/DI H^O. Carbon 14- 
creatinine and vitamin B-^ have been chosen to evaluate the 
mass transfer permeability for middle molecular substances.
2. Membrane effects: Out-dated bank blood will be used 
for examining the overall effects on the membrane. An albu­
min and a hemoglobin test should provide membrane informa­
tion for protein combination. Dextran (molecular weight = 
66,9cQO) and deoxyribonucleic acid (DNA) have been selected 
to determine the membrane effects of large molecules of 
carbohydrate and nucleic acid. The static ultrafiltration 
coefficient and the mass transfer resistance will be meas­
ured first for each bundle as a blank test. The materials
0will be individually evaluated and. data will be collected 
and compared with the blank tests.
3. Checking ordinary research procedures for reuse: 
Ordinary research procedures for reuse can be divided into 
three unit operations which are sodium hypochlorite rinsing, 
hydrogen peroxide rinsing and reverse pressure treatment.
The fibers first will be treated with sodium hypochlorite
or hydrogen peroxide solution. If there is no reaction or 
the reaction does not affect the membrane significantly from
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the physiological viewpoint, the material can be considered 
for reuse. After a blood test, the fibers are to be rinsed 
with a reuse solution or treated with reverse pressure. By 
running these three unit operations individually, the data 
of static ultrafiltration coefficient and the mass transfer 
resistance will be compared with those in the blank tests.
Instead of dialyzers, a portion of a dialyzer or bundle 
(see figure 15) will be used in this investigation. Each 
bundle is made from 150 PAN hollow fibers (about 1/80 of 
the full scale dialyzer). Its effective length is the same 
as the full scale dialyzer but its total trans-membrane area 
is only 1/80 of that of a regular sized dialyzer. Both ends 
of a bundle were placed inside a short piece of plastic tube 
individually and potted with resin to prevent the blood from 
leaking into the dialysate side. The advantages of bundle 
testing are: easy to degas the bundle, easy to repair for
leaks, inexpensive and easy to prepare.
Approximately 40 bundles are to be used in this inves­
tigation. Considerable time and money can be saved if 
bundles of fibers are used instead of the full scale dialy­
zers. The only disadvantage is that the overall mass trans­
fer coefficient, K , (or overall mass transfer resistance,o
R ) of a bundle cannot be scaled up to that of a full scale o
dialyzer.
In full scale dialyzer tests, mass transfer resistance 
of the individual phases in series are additive. The overall
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Figure 15. Picture of a Bundle (PAN Fibers). 
Fiber number = 150 
Effective length = 24 cm 
Inside diameter = 200 to 260 ym.
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mass transfer resistances of the blood, membrane and dialy- 
sate pha-ses. In bundle tests, the bundle Is submerged In a 
large bath with relative high dialysate flow rate, 0.7 1/min, 
the mass transfer resistance of dialysate phase Is then 
negligible In this case.
In dialysis, the dialysate flow rate Is approximately 
two and a half times that of the blood flow rate. This means 
that the mass transfer resistance in the dialysate phase Is 
much lower than that In the membrane phase. Comparison of 
these two cases, bundle tests can still provide consider­




The mechanisms of the human kidney are filtration, 
reabsorption and secretion (see p. 7). Generally, sub­
stances having molecular weights higher than 68,000, can 
not be filtrated from the membrane of the Browman’s capsule 
(see figure 3)* Water and some low molecular weight com­
pounds are reabsorbed in the convoluted tubule (see figure
o3). An average adult human kidney ultrafiltrates 130 cm of
fluid per minute and reabsorbs 129 cm of fluid per minute.
■5This means that only 1 cm of urine is produced every minute. 
The convoluted tubule cells (see figure 3) have the ability 
of secreting and concentrating the urine. The comparison of 
composition between blood and urine and the concentration 
ability of the human kidney are shown in Table 2 (15).
The main mechanism of an artificial kidney system is dif­
fusion and the driving force is a concentration gradient
obetween the blood side and the dialysate side. Although 
the mechanism of an artificial kidney system is different 
from a human kidney, the dialyzer can still excrete waste 
materials, regulate body fluids and sustain the patient’s 
life. When the blood is passing through the semi-permeable 
membrane of an artificial kidney system, the low molecular' 
weight compounds, which are omitted from or are in compara­
tively low concentration on the dialysate side, are removed 
from the blood. Three particle types are shown in figure
T 1765 36




























































From: Jung, J. Y., Human physiology: Shing-Lu Company,
Taipei, Taiwan, second edition, 1965* p. 196.
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16 (16). Solutes which can be removed In 6-10 hours of 
dialysis are listed In Table 3 (17).
Mass transfer coefficient (or mass transfer resistance), 
dialysance, clearance, ultrafiltration rate, blood volume 
and pressure drop in each side are very important parameters 
for evaluation of a dialyzer. Blood volume and pressure drop 
in a dialyzer are expected to be as small as possible. The 
mass transfer coefficient, dialysance, clearance and ultra­
filtration rate are analyzed as follows:
A. Mass Transfer Analysis
1. The distinction between mass transport and mass
transfer is quoted from Keller as follows (18):
"Mass transport refers to the movement of a 
chemical species within a single phase and 
would include such processes as movement of 
species within the plasma or intracellular 
diffusion and simultaneous chemical reaction.
Mass transfer, on the other hand, refers to 
the movement of species across phase bound­
aries as would occur in:
a. Transfer into tissues from circulatory 
system.
b. Transfer across the gas-liquid inter­
face in oxygenators or across the mem­
brane in other kinds of artificial organs.
c. Transfer between plasma and red blood 
cells.
The reason for distinguishing between these 
two is that transfer involves both transport 
and concentration distribution effects at 
phase boundaries."
According to the above statement, the phenomena of 
detoxification from the membrane of an artificial kidney 
system is mass transfer. Both transport and concentration
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16. Diagram for three particle types in 
dialysis.
(a) The represents compounds too large
to pass through the pores in the membrane, 
e, g. red blood or plasma proteins.
^b) The represents compounds in equal
concentration on both sides of the membrane 
so that net transfer occurs, e.g. sodium and 
chloride ions.
^c) The represents compounds omitted from
or comparatively low concentration in dialysate 
side that traversed the membrane and is thereby 
removed from blood, e. g. urea or creatinine.
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distribution effects at phase boundaries should be considered.
2. . Convective flux and diffusion flux: Flux is defined
as the mass crossing a plane per unit area per unit time.
Mole flux and mass flux are two different forms and are rep­
resented as the unit of g moles/(cn£)/(sec) and gms/(cnf)/(sec) 
respectively. Figure 17 represents the different direction 
for two kinds of flux in a control volume. The convective 
flux parallels the overall bulk flow, otherwise the diffusion 
flux is against the direction of overall bulk flow. The 
total molar concentration, C, and the molar average velocity, 
v*, are defined as the equation. (2) and the equation (3)
Z C. = C (2)
J J
Z C. v. = Cv* (3)j J J
where C. and v. are concentration and velocity of species j.J J
Then, the total molar flux of species j is the addi­
tion of convective molar flux and diffusion molar flux and 
it is represented by the following equation:
N. = C. v* + J * (4)J J J
(convective (diffusive 
molar flux) molar flux)
where is the molar flux of species j relative to the
molar average velocity.
3. Nature of the diffusion and the membrane permeabil­
ity: Diffusion is due to random thermal motion of molecules.
It has a tendency to get the thermodynamic equilibrium
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between two phases. After thermodynamic equilibrium, the 
random thermal motion is still continuous, but no net mass 
transfer results.
a. Fick's first law shows the linear constitutive
relations for diffusiona.l flux in a binary system. 
If represents the binary diffusion coefficient 
(diffusivity) for interdiffusion of molecules of 
species 1 and species 2 and for the symmetrical 
diffusion coefficient (D-^ = ^21^’ there are two 
vector forms used usually (15):
in which the are the unit vectors and the x are 
the variables associated with the 1, 2, 3 axes.
If y^ and are present in small concentra­
tions, one may to a good approximation write equa­
tion (6) as (19) :
j x = -D12™ 1 (5)
(6)
where
o)̂  and y^ = mass and mole fraction of species 
1 respectively.
p = mass concentration.




In one dimensional diffusion, equation (7) 
can be written as:
J? = - D ,0 ( 8 )1 12 dx \ '
where dx is the differential distance of the dif­
fusion path.
Ordinary equations in liquid diffusion:
The liquid diffusion coefficient of solute 1 
through a stationary medium 2 is modified by the 
Nernst-Einstein equation (20):
D12 " kT ^  (9)
in which is the "mobility” of solute 1 and
is defined as the steady state velocity (v^) attained 
by solute 1 under the action of a unit force (F^).
The symbols k and T are the Boltzmann constant and 
the absolute temperature respectively. Consider­
ing the "slip" at the sphere-fluid interface, the 
mobility for a rigid sphere moving in creeping flow 
(N^e<<l) is derived from hydrodynamics (21):
II = 3u 2+R1S12
F-L 6Trv2R;L(2y2+Rl e12) K ’
where
^2 = viscosity of the pure solvent, g/cm/sec
= radius of the diffusing solute, cm 
$12 = coefficient of sliding fraction, dimension- 
less .
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There are two limiting cases of interest (22):
i. If there is no slip at the surface of the dif­
fusing particle ($12-*°°), then equation (10) 
becomes Stokes Law:
F1 = 67ry2v1R1 (11)
Substituting the above equation into equa­
tion (9)j one obtains the Stokes-Einstein 
equation:
D = 7-5^—  (12)bFLligff
The Stokes-Einstein equation has shown to 
be fairly good for describing the diffusion of 
large spherical molecules under conditions 
where the solvent appears to the diffusing 
species as a continuum (23).
ii. If there is no tendency for the fluid to stick 
at the surface of the diffusing molecules 
(3i 2^0)j then equation (9) can be changed to:
D = k-1̂1 (13)U 47TR1y2 K15)
For small molecules, equation (13) is a 
better fit than equation (12). 
iii. The Wilke-Chang equation for estimation of
diffusivity of non-electrolytes in liquids at 
low concentration of the diffusing component 
is shown as (24):
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iv.
D° q (X M )0-6
= 7.4 x 10-------^----  (14)
where
= diffusivity of solute at Infinite
dilution, cm/sec.
y = solution viscosity, cp.
X = association parameter, 2.6 for water.
M = solvent molecular weight,w &
V = molal volume of solute at normal boil­
ing point, cc/g.mole.
T = absolute temperature, °K.
The above equation is a reasonable fit for 
dilute solutions of non-dissociating solutes at 
the temperature range from 0°C to 4o°C and usually 
reliable to within +10 percent.
An estimation of the concentration effect on 
is derived by Wilk (25):
D,0y d(ln a,) D 0y o
(  ̂ r y ( > ̂ T 'l dTTrTy^T yl T '2
Dnou o
+ (l - yx) (15)
where
D12y(—^— ) = Stokes-Einstein group for diffusion of
component 1 in component 2 at concentra­
tion y-̂ .
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D12y 0(—ip— ) = Stokes-Einstein group for diffusion of
component 1 in component 2 at infinite
dilution of component 1.
^12^ °(-7p— = Stokes-Einstein group for diffusion of 
component 2 in component 1 at infinite
dilution of component 2.
a^ = activity of component 1.
y^ = mole fraction of component 1.
The term (dlna^)/(dlny^) may be determined from 
vapor-liquid equilibrium data. It is equal to 1.0 
for ideal solutions and approaches 1.0 as y^ 
approaches 1 for nonideal solutions,
v. For electrolytes, the equation of diffusivity 
was reported by Nernst for solute at infinite 
dilution to be (26):
D°2 = 8.931 x 10"10 TC1--^--1--) (|*-+ l~) (16)
X
where 1+ and 1- = cationic and anionic conduct­
ance at infinite dilution, mhos/ 
equivalent.
o 0 0X = 1+ + 1- = electrolyte conductance at infinite 
dilution, mhos/equivalent.
Z+ and Z_ = absolute valence of cation and anion.
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vi. Gordon’s equation modifies the diffusivity 
of the electrolyte at other than infinite 
dilution (27):




r+ = mean ionic activity coefficient based on 
molality.
C = g-mole water/cc. of solution.
Pw = viscosity of water cp. 
y = viscosity of solution cp.
Interfacial equilibrium: After thermodynamic equil­
ibrium is reached, the chemical potential of each • 
species is kept the same in each phase. It does 
not mean that concentrations are the same in every 
case. Based on this concept, the Nernst parti- 
tion coefficient, n., is given as:
((V tt
nj ■ fcJTj ' (l8)
in which (cj )j and (Cj )jj represent the equilib­
rium concentration of species j in two adjacent 
phases I and II.
Normally, n^ is used when the contiguous phase 
are liquid.
Definition of the membrane permeability and membrane 
resistance: There are three different types of
concentration profiles through a membrane. These 
are shown in Figure 18 for no convective effects.
If Dj is the diffusivity of species j in a mem­
brane, x is the membrane thickness and the term
t Tfof (Cj-Cj) represents the concentration difference 
in a membrane, the Pick’s first law can be written 
as:
D (C -C.)
J* = J . J— J—  (19)j A  x
According to the definition, the Nernst parti­
tion coefficient, n^, can be shown as the follow­
ing equation:
C 1 C"
nJ = TcJT^ - (20)
Substituting equation (20) into equation (19) 
one obtains:
J* = ̂  [(Cj)z - (Cj)^] (21)
in which the term of (D^n^/Ax) is defined as mem­
brane permeability, (P^)^, and its reciprocal is 















solute solubility in membrane is“lower than that in 
two reservoirs.
Figure 18, diagram of the concentration distribution of a 
species j diffusing from left to right through 
a membrane.
T 1765 50
The membrane used in an artificial kidney
system has a porous structure. If we assume that
the liquid in the pores is the same as that in the
reservoirs (100$ hydration) and the diffusivity of
species j in the bulk phase Is the same as that in
the pores, n. approaches 1.0.J
In actual mass transfer, the convective trans­
port occurs and the diffusivity changes with the
membrane thickness. This means that D. Is change-J
able through a membrane and is an unknown. The 
effective diffusivity, Is introduced and
defined as (28):
e. Parameters effect an the membrane permeability or
the membrane resistance: There are many parameters
which affect the solute diffusion through a porous 
membrane. This permeation depends on the nature 
of solute and membrane, the environment of solute 
and the interaction among solutes or solute and 
membrane.
i. Solute:
a) Molecular weight (Mo): High molecular weight 
compounds show high membrane resistance.




Except for the non-aromatic and ionized 
species, a log-log plot indicates a linear 
relationship between R̂ . and Mq .
An empirical equation was given by 
Farrell from his investigation (29).
log Rm = 0.861 log Mq - 0.318 (25)
But the data show that lactic acid, 
zwitterionic valine and methionine are not 
well correlated to the above equation,
b) Size: Membrane resistance data do not cor­
relate very well to equation (12) and equa­
tion (13) based on hydrodynamic theory. 
FarrellTs empirical equation (30) gives 
reasonable agreement to experiment data.
This equation represents a linear relation­
ship on log-log plot of assuming spherical 
molecular radius (r^) versus R^.
log Rm  = 2.49 log r2 + 0.080 (26)
where R^ and r2 are represented as (min/cm) 
oand A respectively.
If A2 represents the cross section area
of the assuming spherical molecular (A2 =
2irr2), the relationship between R^ and A2 is 
shown as (31)•
log Rm = 1.235 log A2 - 0.525 (27)
where R^ and A2 are represented as (min/cm)
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o 2and (A) respectively.
c) Polarity or charge affect the permeability 
of a solute. For instance, the rate of 
electrolyte diffusion is controlled by the 
diffusion of the co-ions.
d) Other effects on a solute diffusion are 
solute conformation, degree of solvent 
hydration and solvent environment.
ii. Membrane: The structure of a membrane deter­
mines the permeability of a membrane. But the 
methodology for determining membrane structure 
is not definitive. Van der Waal's forces, 
hydrogen bonds, hydrophlic or hydropholic inter­
action and charge transfer bonds may be affect 
the transfer character of a membrane. These 
factors and manufacturing technique decide the 
structure of a membrane.
The relative crystalline to amorphous con­
tent in a membrane may be an important factor 
for determining the membrane structure, but it 
needs more investigation. For a structure 
fixed membrane, the pore size and its distri­
bution control the membrane permeability.
Fixed charge or polarity in a membrane usually 
affects electrolyte diffusion. For instance, 
cellophane behaves as a weak ion-exchange
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membrane (it excludes negative ions and takes 
up positive ions).
A very important term used in the membrane 
investigation is selectivity. It is defined 
as the ratio of different solute permeabilities 
for the same membrane. Hydration*is another 
parameter for membrane permeability. The 
higher the hydration of a membrane, the lower 
the selectivity for water soluble solutes and 
nonionic membrane materials. For 100 percent 
hydration membrane, the membrane permeability 
is equal to the term (D/Ax). For low hydra­
tion membrane, the molecular size of diffusing 
solute becomes important. Figure 19 shows the 
membrane permeabilities as a function of hydra­
tion (31). Most investigators agree that 20 
percent is the minimum hydration to insure 
sufficiently fast transport,
iii. Temperature: The Arrhenius equation may be used
to show temperature effects on the membrane 
permeation.
Deff = Do exp (-Ea/RT) <28)
or
*Hydration is defined as: (weights of water in membrane)/
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log Rm = log R° + |5. I (29)
where Ea is the activation energy and Dq or 
is the effective membrane diffusivity or 
membrane resistance at (i) approaching zero. 
Equation (29) shows the linear relationship 
in the semi-log plot of log versus (^). 
Experimental resistance data fit very nicely 
onto a straight line for aromatic or non­
electrolyte solute (32).
4. Overall mass transfer coefficient and overall mass 
transfer resistance:
a. Definition: The combination of convective and dif­
fusive mole flux changes the linear concentration 
distribution in the blood and the dialysate phases 
(figure 18). Figure 20 shows .the velocity pro­
files and one form of concentration distribution 
in the three phases of a dialyzer. This concen­
tration distribution is difficult to analyze 
theoretically and the term of an overall mass 
transfer coefficient, (Kj )q , is introduced. It 
is defined as:
Nj = (V o  [(cj }b - < V d ] (30)
where (C,). and (C.), are bulk concentration of J b j d
species j in the blood and the dialysate phase 









Figure 20. (a). The velocity profiles and flux direction.
(b). The qualitative concentration distribution,
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as the overall mass transfer resistance, (Rj )q .
(V o “ tkJ7;  (31)
If (K.), and (K.), represent the mass transfer 0 b j d
coefficient in the blood and the dialysate phases 
respectively, the total mole reflux equations in 
each phase are shown as:
Nj (V b  C(CA  - (V i ] (32)
N. = — [cl  -  c’f]
.1 x j
D .n.
~ E ~ x ~ ^ cĵ i “
(pj)M
Nj = ^ CJ^II “ ^Cj^d3
where (C.), , (C.)T , (C.)ttj C 1., c " and (C.), are j b J I J II j J J d
concentrations at different points in the diffu­
sing path and are shown in Figure 20 (b).
If Nj is everywhere constant, one can combine 
equation (32), equation (33) and equation (3*0 and 
obtain the following equation.
Nj = { J ■ J ■ I > [(Cj)b-(Cj)d ] (35)^  ^  ^ 9 2
The reciprocal of (Kj)b and are defined
as the resistance in the blood phase, (pj)g> and
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the resistance in the dialysate phase, 
respectively. Comparing equation (30) and equa­
tion (33) and using the definition of (Rj )q ,
(Rj )B , (Rj)^ and (Rj )m> one obtains:
w : = ^ + ^ + w i  (36)
(V o  ■ (Rj }B + < V m + (Rj>D (37)
Equation (37) means that the overall mass trans­
fer resistance is the sum of the individual mass 
transfer resistances of the blood, membrane and
dialysate phases. w ̂^ 7̂ o r t .*4 CCj L~' ob. Nature of the overall mass transfer coefficient: < ̂  co
R 3 °
The value of K for a species depends on the dif- ^ o <
TJ}. ■ j 95
fusivity of a membrane and the state of motion of b b
with a change in conditions. This is important 
for design and evaluation of more efficient dialy- 
zers. Figure 21 shows that the relative mass 
transfer resistance is a function of solute molec­
ular weight for the Kolff twin coil (3^). Accord­
ing to this figure, if one reduces the membrane 
resistance he will obtain a significant diffusion 
of middle and high molecular weight compounds.
If the Sherwood number (Ng^), Schmidt number 
(Nsc ) and Reynolds number (N^e ) are defined as the
CQ
oJo
r-1 Q °the fluid. The relative magnitude of the overall p a izfP R pq 



































.Figure 21. Relative resistances for Kolff Twin 
Coil as a function of molecular we­
ight at Qb = 200 ml/min (Visking 
tubing as membrane)
From: Gotch F. A. e£. al. "The Evaluation of Hemo-





NSC ■ Djp (39)
N„ = (40)Re y
where
L - the Prandtl mixing length, 
y = viscosity, 
v * velocity, 
p = fluid density.
Dj = diffusivity.
K - overall mass transfer coefficient, o
Then one can find some relationship among Nsh* NSc 
and N^e for different types of dialyzer in differ­
ent methods of dialysis. The general relationship 
can be shown as:
NSh - f<NScNRe> (41)
Figure 22 (35) and Figure 23 (36) show the over­
all mass transfer coefficient is a function of the 
flow rate in blood and dialysate phases. 
Determination of individual resistance in the differ­
ent phases: The procedures to determine (Rj)g*
(Rj)^ and (Rj )d under certain conditions are shown 
as:
Q-p (1/rain)
Figure 22. The effect of dialysate flow rate 
on the overall mass transfer coef­
ficient.
From: Bahb A. L. et al. "The determination of 
membrane Permeabilities and Solute Dif- 
fusivities with Applications to Hemodi­
alysis". uhem. Eng. Progress, Symposium 




Figure 23. The effect of blood flow 
rate on the overall mass 
transfer resistance.
From : Buffaloe, G. , and Collins, C. M . ,
An investigation in Cobe Lab. Inc. 
Lakewood, Colo. 1974.
100 ZOO 25 7 8 9 1001
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i. Measure (R.) under a dialysis conditionJ o
(see item C).
ii. Measure (r j )q under different dialysate 
flow rates (QD ).
iii. Plot a figure of (Rj)Q versus QD and find 
the critical in which the mass transfer 
resistance approaches zero. The overall mass 
transfer resistance under the dialysate flow 
rates which are higher than critical QD means
that:
(Vo Qd > critical
(Rj)B + R̂j ̂ M
iv. Then the mass transfer resistance in the
dialysate phase under a dialysis condition can 
be found from procedure i and procedure iii.
v. Measure (R.)M by using a single membrane method, 
double membrane method, double channel height 
method or dynamic permeability determination 
method for a given membrane (37).
vi. Under a given dialysis condition, if (Rj)0
measured from procedure i, (^j)^ measured
from procedure iv, and (^j)^ measured from
procedure v, then (R.)^ can be calculated fromJ t>
equation (37).
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5. Dialysance and clearance:
a. • Definition: Dialysance, Dg, is defined as the
solute removal rate divided by the concentration 
difference between incoming blood and incoming 
dialysate (38). It can be represented by the fol­
lowing equation:
QBi CBi “ QBo CBo _ QDo CDo " QDi CDi ti\
B “ CBi - CDi " CBi " CDi
Clearance, C*, is defined on page 17 and can be
represented by the following equation:
c* = QBi CB1 ~ QBo CBo = QPo CDo ~ QPi CD1 
CBi CBi
If there is no ultrafiltration the flow rates in
both phases are constant, then equation (1) and
equation (43) reduce to:
C-p.. — C-q - c~.
dr = 7 ^  qb = c - c qb (44)Bi “ Di Bi Di
CD, - C-, Cp, - c„.c* = _§i_-Bo q = -Do  Di Q (i(5)
Bi B Bi B
In the case of single pass dialysate, the con­
centration of dialysate-in is zero for the solutes 
being excreted. In this dialysis, the clearance 
is equal to the dialysance.
b. Derivation of equations in three different methods
of dialysis:
i. Dual single pass: In this kind of dialysis,
all the concentrations of blood-in, dialysate-
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in and dialysate-out can be measured after 
equilibrium. If there is no ultrafiltration, 
the dialysance and the clearance are calculated 
from equation (44) and equation (45). This 
method only runs in vitro (outside the organ­
ism) for evaluation of a dialyzer. The tests 
for small molecule compounds always use this 
method for saving time,
ii. Single pass in dialysate and closed loop in
blood side: In this case, is kept the same
(C~. = constant), but both C^. and are Di 9 Bi Bo
functions of time. Figure 24 shows the dia­
gram of this case. In vitro (outside the 
organism) test the blood in the flask is well* 
mixed by a magnetic stirrer.
There are two assumptions that must be met:
a) There is no ultrafiltration in a dialysis
o
and the flow rates in blood and dialysate 
phases are kept constant.
b) The human blood volume (in vivo) or the 
blood volume in flask (in vitro) is much 
larger than the tubing set volume and the 
dialyzer blood volume.
The first assumption gives a constant total 
blood volume, Vg, which includes the human 
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(In vitro), the tubing set volume and the 
dialyzer blood volume. The second assumption 
shows that the solute concentration In the 
blood phase of a dialyzer approaches that in 
the human body (in vivo) or the flask (in vitro). 
This means that Cg approaches
According to the meaning of the differen­
tial form of concentration driving force, one 
obtains:
V R dCR
CBi CBo dt-  (46)
Substituting equation (46) into the defin­
ition of dialysance and clearance, one obtains:
VR dCRiD = ---- -----  — _  (47)d b cB1 - CDi dt
VR dCFH
C* = 4  (48)
After integrating from time o to time t, 
one obtains: 











where C° and C^. are the blood concentrations
in the flask at time o and time t.
If the solute concentration of dialysate- 
in is zero, equation (51) is equal to equation
(52), and Dg is the same as C*.
iii. Dual closed loop: In this case, both concen­
trations in the blood and the dialysate side 
are functions of time. Except for the same 
assumptions as the above case, the dialysate 
volume in flask is assumed to be much larger 
than the dialyzer dialysate volume and the 
tubing volume. Under these assumptions, one 
has:
a) = constant
b) Vg - constant
c) Cg = Cg^ (the concentration in flask in
blood side)
d) Cg - CDi (the concentration in flask in '
dialysate side) 
where Vg is the same as the above case, Vg in­
cludes the dialysate volume in flask, the
T 1765 69
tubing set volume and the dialyzer dialysate 
volume. Figure 25 shows the diagram of this 
case. Both the blood and the dialysate In the 
two flasks are well mixed by a magnetic stirrer 
Because there Is no CD term In the defini-
^ Q  __ C
tlon of clearance (C = —^ — —  Qr ) , the deriva-cBi
tlon for clearance reduces to the same equation 
as equation (52). But the values of clearance 
In this two closed dialysate loops are differ­
ent .
For total mass balance3 one can set the 
following two equations:
M = °Bi VB + CDi VD (53)
= °Bi VB + CDi °D (54)
where
M = total moles of a solute.
Cgi and = patients or flask blood concen­
tration at time zero and time t. 
0°^ and CDi = flask dialysate concentration at 
time zero and time t.
Combining equation (53) and equation (5*0 
one obtains:
CDi = (CBi VB + CDI VD - CBiVB )/VD (55)
Substituting equation (55) into equation




















































In this case, all of the values In the right 
side of equation (57) can be measured and the 
dialysance can be calculated from the above 
equation.
Because the overall mass transfer resist­
ances are high for middle and large molecule 
solutes, It shows a small concentration differ­
ence between blood-in and blood-out of a 
dialyzer. This Is the difficulty In using the 
first method to evaluate their mass transfer 
properties for the middle and the large mole­
cule substances. The 2nd and 3rd methods 
appear to alleviate the difficulty in deter­
mining the mass transfer properties. The in 
vitro test, the blood and dialysate volume in 
flask is usually 10-15 times of that in the 
dialyzer and the tubing set volume is kept to 
a minimum.
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c. Operational conditions affecting clearance of
dialysance: There are many investigations of clear­
ance or dialysance in the last ten years. The fol­
lowing twelve figures show the clearance (or dialy­
sance) as a function of solute molecule weight, 
blood flow rate, dialysate flow rate, flow geometry, 
overall mass transfer coefficient, and total mem­
brane area. Under ordinary dialysis condition of 
single pass in dialysate side, the clearance is the 
same as the dialysance.
i. Figure 26 shows that clearance is a function
pof molecular weight for 1 m surface area of 
high flux cellulose acetate Dow kidney in vivo 
data (except vitamin B ^ )  (40).
©
ii. Figure 27 shows the relationship between Dg 
and Q-n. Figure 28 shows that D„ is a function
JD iJ
of Qg (4l). Figure 29 represents that the 
effect of high Qg on clearance for small mole­
cules is more sensitive than that for middle 
molecules (42).
iii. Figures 30, 31 and 32 show the relationship 
between the dialysance ratio (Dg/Qg) and 
(Qg/Qg) with the solute-transport ratio (Ka/Qg) 
as a parameter for three different flow geom­
etries (43). Figures 33 and 34 show clearance 



















Figure 26. Clearance (Q& = 200 ml/min, Q0= 500 ml/min)
xas a function of molecular weight for 1 m 
High Flux celluloses Acetate Kidneys in vivo 
data (except vitamin B (i)
From: Sargent J. A. et al. "Research on Improved Hollow 
Fiber Artificial Kidney" Dow Chemical U. S. A. 
December 1972, p13.
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Figure 29 In vitro experimental results showing the effect 
of Qq on the clearance of a standard Kill hemodialyzer for 
a small and ’’middle molecule".
From: Babb A. L. et. al. "The Genesis of the Square Meter-
Hour Hypothesis". Trans. Amer. Soc. Artif. Int. 












The relationship between the dialysance ratio 
(Dp/Qg) and (Q3/Q3 ) with the solute-transport 
ra£io (KoA/Qg) as parameter in parallel flow 
(cocurrent flow) geometry.
Michaels A. S. "Analysis of Membrane-transport 
Device". Trans. Amer. Soc. Artif. Int. Organs, 










1.0 1.2 1.4 i.a0 0.2 04 0.6 00 16 2.0
77
Figure 31• The relationship between the dialysance ratio 
(D3/Q3 ) and (Qb/Qd) with the solute-transport 
ratio (KoA/Qb) as parameter in countercurrent 
flow geometry.
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Figure 32, The relationship between the dialysance ratio 
(Dt*/Qt}) and (Qp./Qq ) with the solute-transport 
ratio' (KoA/Qg) as parameter in well mixed 
dialysate flow geometry.
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Figure 33. Dialyzer clearance versus blood flow rate with 
Qq = 500 ml/rain for various values of KoA.
From: Babb A. L. et. al. 11 The Genesis of the Square
Meter-Hour Hypothesis". Trans. Amer. Soc. 
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Figure 3U* Dialyzer clearance versus dialysate flow rate 
with Q_ = 200 ml/min for various value of KoA,o
From: The same reference as Figure 33.
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KoA (42). Figure 35 represents the clearance 
as a function of (KoA) with the parameter of
Qg for three different flow geometries (4l).
6. Determination of the overall mass transfer coef­
ficient and the relationship between K and D„ in three dif-o B
ferent flow geometries and three different methods of dialysis:
The overall mass transfer coefficient is a function of the
flow geometries and the methods of dialysis. After the deri­
vation of overall mass transfer equations, one can follow the 
definition of the dialysance and the principle of mass bal­
ance to find the relationship between Dg and KQ . All the 
derivations of overall mass transfer coefficient and its 
relationship with Dg in three different flow geometries and 
three different methods of dialysis are shown in Appendix A.
All these equations are derived under the assumption of no 
ultrafiltration. Figure 36 shows the diagram of three dif­
ferent flow geometries. Figure 24 and 25 show the diagrams 
of two different methods of closed blood dialysis (dialysate 
single pass and dialysate closed loop).
a. Dual single pass dialysis: The overall mass trans­
fer coefficient are in terms of A, Q^, Q~ and theB JJ
concentration and the relationship between K0 and
D„ in three different flow geometries are shown as:B
i. Countercurrent flow geometries:
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a. Countercurrent Flow Geometry
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♦ c* V/ell Mixed Dialysate Flow Geometry 
Figure 36. Diagram For Different Flow Geometries.
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Ko =  Qb q In [ ^ B o S l ] (58)
A (1 _ %
D
- QR (1-Dr /Qr )
K o  H r  ln H O T  (59)
A(1 - A  B D
D
037 i  r / K o A n / ,  QB n1-exp[ - ( 1  - p-)]
db " qb { o  --------   o---} (6o)
1  B  p v n  r  f K o A W l1 “ 7T exp L-(p ) (1 - p ) ]
%
11. Cocurrent flow geometries:
k o  =  — - - V -  m  [ £ § 2 ^ 2 ° ]  ( 6 1 )
A(1 + %
Qp> Bp» Q-dK o --------------- in [1 B (! + B )] (62)
A(1 + A  B D
yD
or
DB = - ^ - { l - e x p [ - ( | A ) ( l  + ^ ) ] >  (63)
1 + —  B D0D
ill. Well mixed dlalysate flow geometries:
Ko - - In [rBo -r-Do-] (64)
A Bi Do
Dr Q-q




1 - exp (- KoA
QB1 + q— [1 - exp (-
(66)
’D
The results of the relationship between 
dialysance and overall mass transfer coefficient 
(equations (59), (60), (62), (63), (65), and 
(66) match with the previous results reported 
by Michaels (43).
b. Blood closed loop and dialysate single pass dialysis: 
Under the assumptions of no ultrafiltration, rela­
tive enough large and well mixed blood reservoir, 
the overall mass transfer coefficient and its rela­
tionship with D-p are derived for three different
flow geometries (see Appendix A):
i. Countercurrent flow geometry: The results of
derivation of Ko and its relationship with Dg 
were first reported in 1973 (^4). The results 
of the derivations in Appendix A are consist­
ent with the results of this investigation.
Ko




ii. Cocurrent flow geometry: A similar deri­
vation shown in Appendix A results in the 
following equations for this case:
----------------------------- S '  { 1  ( v  +  Q r ) l n [ 'r c B 1 - c -D1- r ] }A(1 + ^ )  B D Bl Dl o
D
S  = - ^  m  + (70)
1 + S
iii. Well mixed dialysate flow geometry: The 
derivation shows semilar results as (see 
appendix):
(VB )ln[?CB1"CD1!t]Q S Bt ;inL(CR,-Cr),)oJ
Ko = - -jS ln {— 2™--------- ■ -Di- -- + 1} (71)
B \n„ r Bi Di t-10 t 7”r —C } 0C°Bi Di o
r-i / Ko A \ -1[1 - exp (- Q— )]
Dr = Qr { q------------ -------- } (72)
, B He / KoA n1 + n~ [1 - exp (- ■=— )]
yB
Dual closed dialysis: Except for those assumptions
in the above case, the assumption of relative large 
and well mixed dialysate reservoir is needed in 
this case.
i. Countercurrent flow geometry: The result of
Babb’s derivation of Ko in 1972 was given as 
equation (73). The derivation in this inves­
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( V W  c ° ±  -  c g ±
qr1 - exp [-(KoA/Qg)(1 - q— )]
DB = QB { ~  ^ ~ } ^75)
If one substitutes the relationship of mass 
balance (equations (53) and (5*0) into equa­
tions (73) or (7*0 > he will find the same 
result between these two equations. When equa­
tion (73) is used, one more sample, ( ^ta 
needed. Because and should be taken at
the same time, equation (7*0 is useful since the 
parameters are easily measurable,
ii. Cocurrent flow geometry: The differences
between previous results and this investiga­
tion are one different sign and one more term
(Q„) in this investigation.B
a) The previous report (46) shows the blood
concentration in the reservoir (C^) ina
terms of C°i5 Vg, Vg, Qg, Qg, A and
Ko.
v l-exp[-KoA(»—  + — )]
D ,no _o . , %  ,1 . 1 x. ,
( C ^ - C ^ ) e x p { --------------------------------- „ -------------------------------------- ( = r -  +  ^ r - ) t }V V  B1 Qb v̂ b vd
qd
+ (V T ^ )Cb1 + V̂ D + VB )Cd1 (76)
After rearrangement, one obtains: 
QB
q rA(1 + A
%
Qr V V CB (1 + (CDl+CBi VD )
ln{l-(l+ B)[ B D  ]ln[---------2— --------- 2-]}
D B D <CBi-CDi)
(77)
b) The derivation of this investigation shows 
that (see Appendix A):
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Db = ( - % - )  {1 - exp [-(|2A) (1 + ?&)]} (79)
1 . B B D
q d
iii. Well mixed dialysate flow geometry: Fol­
lowing the same procedures as the above 
two cases, one has the results derived in 
Appendix A:
(1+ —— — (C° ^ + c° )Vnyn U +  Vn Bi Bi Vn °Di;
ln[ °--------]Q Q (V +V )t XI‘L (cfi.-CO)
Ko = - ln{l+ -B B D-------------- ------------------------
i+ VbVd (1+Vp/Vn)cp.-(C° V_/Vn+C2.)
1+ $L (V '+ V ") l n [  P. ■ P. - -P1. ■ ■ B l B D D l
L) a U fn "\(0B1 Dl
(80)
1 - exp (- n ^ )
°B = QB { Q--------~  > (81), B [•■! / KoA \ n
1  +  r T  [ 1  "  exP ( -  n—yD yB
In dialysance analysis, the equations of in
terms of Ko, A, Q_, and are equal for theD U
same flow geometry but different methods of 
dialysis.
If the dialysate flow rate, Q^, is very 
high (its reciprocal approaches zero), all 
the above dialysance equations will be changed 
to the same form shown as equation (82) in 
the special case.
Db = Qb [1 - exp (- |2A)] (82)
B
T 1765 88
B . Ultrafiltration Rate
1. Definition: The ultrafiltration rate is defined as
the fluid removal rate for ultrafiltration in a dialysis.
It is due to the hydrostatic and the osmotic transmembrane 
pressure gradient. The following equation shows the rela­
tionship among three kinds of ultrafiltration.
U = U. + U (83)o h osm
where
U - the total ultrafiltration rate, o
U^ = the ultrafiltration rate due to the hydrostatic
transmembrane pressure gradient.
U = the ultrafiltration rate due to the osmotic asm
transmembrane pressure gradient.
2. Nature of the ultrafiltration: The hydrostatic
transmembrane pressure gradient,AP^, is the difference 
between the average blood pressure and the average dialysate 
pressure. This is one of the driving forces of the ultra- 
filtration. Equation (84) shows the calculation of the 
hydrostatic transmembrane pressure gradient.
A  p”  = I (p + p ) _ — (p + p  ) (84)M 2  ̂ Bi Bo 2 1 Di Do;  ̂ ;
where ^go* ^Di an(̂  ^Do rePresen  ̂ the pressure of blood-
in, blood-out, dialysate-in and dialysate-out. Figure 37
shows a linear relationship between Ap^ and (47).
The net effective transmembrane osmotic pressure is the
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AC'osm5 multiplied by the reflection coefficient of the mem­
brane fo.r the molecule, a.
_ n _
A P  = Z (AC a). (85)^ osm osm 1
The reflection coefficients, a, are determined by the 
so-called pore size of the membrane relative to the size of 
the molecules, and are thus related to permeability (48,49) -
The fluid removal rate per unit membrane area per unit
transmembrane pressure gradient is called ultrafiltration
2 2 coefficient, and represented as cc/min/m /mmHg or cc/hr/m /mmHg.
Figure 38 shows the observed relationship between the
mass transfer coefficient for vitamin and the ultrafil-
2tration coefficient in 2 m cellulose acetate artificial kid­
ney (50). The ultrafiltration coefficient can be used as a 
quantitative description of the membrane properties to a 
limited degree.
3. Static ultrafiltration: The static ultrafiltration
rate is defined as the ultrafiltration rate under the con­
dition of no bulk flow on the blood side by clamping the 
venous side of a dialyzer. In normal operation, there are 
two ways for measuring the static ultrafiltration rate. By 
keeping atmospheric pressure in the dialysate side and by 
pressurizing the air from a tube before the arterial side of 
the dialyzer, one gets a positive blood pressure. Another 
method is by opening the arterial side and maintaining a 
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the first method, the positive blood pressure, is chosen to 
measure the static ultrafiltration rate. The static ultra­
filtration coefficient, U , is defined as the volume removalsc5
rate from the blood phase per unit membrane area per unit
transmembrane pressure gradient and is represented with the
2units of ml/hr/mmHg/m .
U = — !--------------------------  (86)
Sc AP t A M t
For hollow fiber: = dL N
(I„ = ---------------------------------------------------(87)
sc dL N t APm
where
V = ultrafiltration volume, ml.
t = ultrafiltration time, hr or min.
2A^ = total transmembrane area, m .
d = average diameter of the hollow fibers, m.
L = average effective length of the hollow fibers, m.
N = total number of the hollow fibers, dimensionless.
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EXPERIMENTAL DESIGN
Experiments are designed for:
A. Evaluation of the mass transfer for PAN fibers.
B. Evaluation of the membrane effects on mass transfer 
for different biochemical —  blood, albumin, hemoglobin 
dextran, and DNA.
C. Evaluation of the membrane effects on mass transfer 
for ordinary unit reuse treatments (which are under research) 
—  sodium hypochlorite rinsing, hydrogen peroxide rinsing and 
reverse pressure treatment.
The static ultrafiltration coefficient and the overall 
mass transfer coefficient are compared between data measured 
before and after different material testing or ordinary 
reuse treatment.
A. The Preparation of Bundles
The polyacrylonitrile (PAN) fibers used for the membrane 
evaluation are made by Cobe Laboratories, Inc., Lakewood, 
Colorado. The bundle is made up with 150 PAN hollow fibers 
(see figure 15) having the same effective length as a clini­
cal dialyzer (approximately 24 cm). The total membrane area 
of a bundle is only 1/80 of a regular-sized Cobe PAN dialyzer. 
The inside diameter of the fibers ranges from 200 pm to 260 pm 
and can be evaluated by measuring several using a micro­
scope .
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One hundred and fifty PAN fibers in a short plastic 
tube are potted with resin for separating the blood side 
and dialysate side. Before running the experiment, the 
fluid inside the fiber, glycerine, should be rinsed out by 
RO/DI H^O (reverse osmosis and deionization water). Each 
bundle should be leak tested to make sure of its condition 
before being tested. Bundles having potting leaks will not 
be used in these experiments. Fiber leaks can be eliminated 
by hot clamping the fiber. All of the bundles are stored 
inside the 0.002$ formaldehyde solution and kept in storage 
at 5°C to minimize reaction with bacteria.
B. Static Ultrafiltration Coefficient Measurement
The RO/DI H^O is used in both sides to keep an osmosis * 
gradient. The entire bundle is submerged horizontally inside 
a RO/DI H^O bath (37°C i0.10°C). Before each run, the bundle 
should be degassed completely by following the technical pro-
0
cedures. The blood fluid flows in a long tube before passing 
through the bundle. At least 1 foot of the tube is submerged 
in the bath to keep the fluid at a constant temperature 
(37°C t 0.1°C). The transmembrane pressure includes the 
pressure from PTU (pressure test unit) and hydrostatic pres­
sure. The pressure from PTU is shown in the PTU and man­
ometer as a double check. After clamping the venous head of 
a bundle and pressurizing the air through to the blood fluid, 
the time is measured for ultrafiltrating a fixed volume of
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blood fluid (0.2 ml). A pipette is used for measuring the 
ultrafiltration volume and a timer (or stop watch) is set 
for counting the ultrafiltration time. If the ultrafiltra­
tion volume, ultrafiltration time, inside diameter, effec­
tive bundle length, fiber number and transmembrane pressure
are measured, the ultrafiltration coefficient, U can be ’ ’ sc
calculated by following the equation (87) in the theory.
C . Overall Mass Transfer Coefficient (or Resistance 
Measurements)
This experiment is designed by setting the bundle inside 
a 600 ml well mixed (using magnetic stirrer) container which 
is connected to a 70 1. reservoir and a relatively high dialy­
sate flow rate (0.7 1/min). In this condition, the dialy­
sance concentration is kept constant during the experiment.
It is considered as the well-mixed dialysate flow geometry. 
Single pass in the blood side is chosen in these experiments 
and equation (64) in the theory is suitable for calculating 
the overall mass transfer coefficient of the bundles. Both 
sides (blood and dialysate side) are kept at 37°C i 0.1°C.
A solution of 0.9 gm$ sodium chloride is used for approach­
ing the condition in human blood and reducing the osmolarity 
difference on both sides. Blood fluid was pushed by a 
roller pump and kept the flow rate about 2 cc/min. Before 
the experiment, all of the fibers should be degassed com­
pletely. The mass transfer coefficient can be evaluated by
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the concentration difference between the arterial and the 
venous side. The concentration change can be measured from 
the change of optical density or intensity of radioactivity. 
Ten minutes for equilibrium is needed before taking samples.
Chemicals used for evaluating mass transfer coefficient 
in this investigation are:
Vitamin B ^  (molecular weight 1355). —  In spite of its 
low concentration in human blood, vitamin B ^  can used to 
evaluate the membrane permeability for large or middle molec­
ular weight materials which can be diffused from the membrane. 
By setting the wave length at 361 my and measuring the 
optical density of the blood-in, the blood-out, and the 
dialysate-out, one can calculate the overall mass transfer 
coefficient from equation (64).
Creatinine (molecular weight 113). —  In the human body, 
creatinine is cyclized from phosphocreatine and excreted in 
the urine (see figure 39) (51).
For an average weight male adult, the creatinine loss 
is not trivial —  1.7 g per day and remarkably constant. It 
means that a constant fraction of the phosphocreatine is 
broken down each day to form creatinine. Having a low 
molecular weight (113 g/mole), it has a high mass transfer 
permeability in either the human kidney or an artificial 
kidney (dialyzer). Any decrease in the mass transfer coef­
ficient is a sensitive indicator of the change in membrane
14condition. Using a C radio-isotope or setting the wave
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length at 234 ym and measuring the optical density, one can 
evaluate the overall mass transfer coefficient of the mem­
brane. In this investigation measurement of radioactivity 
14intensity of C - creatine of the blood-in, the blood-out 





N C = 0
H 0
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Phosphocreatine Creatinine
Figure 39- Phosphocreatine spontaneously cyclizes with the 
loss of Pi to form creatinine, which is excreted 
in the urine. From: McGilvery, R.W., Biochemis­
try, 1970, p. 424.
D. Materials Tested for the Membrane Effects on Mass Transfer 
Different materials (blood, albumin, hemoglobin, dextran 
and deoxyribonucleic acid (DNA)) are chosen to evaluate the 
change of membrane condition. Three or more bundles are used 
in each evaluation. First, the static UFR and the overall 
transfer coefficient (or resistance) of creatinine and vita­
min B-« are measured for each bundle. Then these bundles 12
are separated to five groups and blood, albumin, hemoglobin, 
dextran (M.W. = 66,900), or DNA (deoxyribonucleic acid) is 
flowed for one hour respectively. After the reaction or
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binding occurs between the material and membrane, the static 
UFR and the overall mass transfer coefficient or (resistance) 
are measured again. From the change of percentage of the 
static UFR and the overall mass transfer coefficient (or 
resistance) between the data measured before and after the 
experiment, effects of these materials on the mass transfer 
of the membrane will be evaluated.
1. Blood: Human blood was from a blood bank (Bonfils
Memorial Blood Bank, Denver, Colorado) for these experiments. 
In order to decrease the blood coagulation effect, dilution 
and addition of the heprin is required. After filtration, 
the bank blood is diluted (in saline) to one-third of the 
original concentration. Five ml heprin per liter blood 
saline solution is added to keep from coagulating. Then 
keeping blood temperature at 37°C and setting the blood 
flow-rate, Q^, at 2 cc/min, it is run for one hour.D
2. Albumin and Hemoglobin: The average concentration of 
hemoglobin in human blood is 13-17 gm/100 ml and for al­
bumin, it is 3.5—4.9 g/100 ml (52,53). These are the main 
proteins in human blood. The experimental parameters for 
both materials in these experiments are:
a. Concentration: 4 g/100 ml saline (for both
compounds)
b. Flow Rate: 2 cc/min.
Ci Temperature: 37°C t 0.1°C ARr:" ', ;r i ' 1Y
d. Effect Time: 1 hour
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3. Dextran and Deoxyribonucleic Acid (DNA): In order
to know -the membrane effect for large molecular material of 
carbohydrate and nucleic acid, dextran and deoxyribonucleic 
acid are used in these experiments. The former material, 
dextran, occurs with various kinds of structures. Dextran 
used in these experiments is only one of this group having 
a high molecular weight, 66,900 gm/mole. DNA is a poly­
nucleotide which is also a macro-molecule. Its membrane 
effect can provide us with information on nucleic acids.
The experimental conditions for these two materials are 
designed as:
a. Concentration: 2 g/100 ml saline (for both
compounds).
b. Plow rate: 2 cc/min.
c. Temperature: . 37°C t 0.1°C.
d. Effect time: 1 hour.
E. Membrane Effects for Ordinary Reuse Research Procedures
Prom the literature survey, there are several procedures 
used for reuse after dialysis. After running bank blood for 
one hour and washing with saline for fifteen minutes, three 
reuse procedures, sodium hypochlorite rinsing, hydrogen 
peroxide rinsing, or reverse pressure are individually used.
1. Blank test: The experimental condition of blank
test are shown as:
a. Concentration:
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I. Sodium hypochlorite solution: one-tenth of
market Clorox in RO/DI water.
II. Hydrogen peroxide solution: 3.0# H2°2 in
water solution.
b* Testing time: 2 hours.
c* Temperature: Room temperature (22°C t 0.5°C).
d. Plow rate: 0.0
2. Sodium hypochlorite or hydrogen peroxide solution 
rinsing after human blood: The experimental conditions are
shown as:
a. Concentration:
i. Sodium hypochlorite solution: one-tenth of
the commercially available Clorox in RO/DI 
water.
ii. Hydrogen peroxide solution: 3.0# H2°2 ln
water solution.
b. Rinsing time: 15 minutes.
e* Temperature: Room temperature (22°C ± 0.5°C).
d. Rinsing flow rate: 8.5 cc/min.
3- Reverse pressure: The dialysate side is kept a
constant pressure by clamping one end and pressurizing the
other end (using PTU). There is saline flowing in the blood
side and no flow in the dialysate side. The experimental 
conditions are shown as:
a. Reverse pressure: 300 mmHg.
b. Treating rate: 30 min.
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c. Flow rate
i. Blood flow rate: 8.5 cc/min.
. ii. Dialysate flow rate: 0.
d. Temperature: Room temperature (22°C ± 0.5°C).
e. Blood fluid: saline.
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EXPERIMENTAL APPARATUS
A photograph of the experimental apparatus is presented 
in Figure 40. Figure 4l is a photograph which shows the 
well mixed dialysate for measuring Ro. Figure 42 and Figure 
43 illustrate the functional relationships between the vari­
ous pieces of equipment for measuring the static ultrafil­
tration rate and the overall mass transfer coefficient (or 
resistance). Supplying air at 200 mmHg is pressurized by using 
a Cobe pressure testing unit (PTU). The pressure can be read 
from the Cobe PTU and the manometer for double check. It 
drives the water in the pipette, the tube and bundle to 
ultrafiltrate at a constant rate from the membrane of the 
bundle if one end of the bundle is clamped by hemostat. A 
one-foot tube and bundle are submerged in a water bath whose 
temperature is set at 37°C t 0.1°C and controlled by the use 
of a thermostat (Thermomix). The ultrafiltration time is 
measured by the timer.
A detailed description of the various pieces of equip­
ment shown in Figure 4l is as follows:
Cobe Pressure Unit (PTU) —  The Cobe PTU consists of a 
very rugged polished stainless steel compact canister, a 
aneroid manometer, inflation bulb, tubing, and universal 
connector. The operating pressure range is 0 to 300 mmHg.
Thermomix Junior Immersion Thermostat —  It is CTU-22 
model manufactured by B. Braun Mclsungen Apparatebau in West
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Figure 40. Photograph of the Experimental Apparatus.
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Germany. The tubular heater transfers the heat produced to 
the bath. The stirrer rotates at about 1800 rpm and dis­
tributes the heat throughout the bath. The temperature can 
be checked by means of a reference thermometer.
In measuring the mass transfer coefficient (or resist­
ance), material which will be tested is pumped out by a 
dextrose metering pump and pass through the bundle which is 
set in a well mixed dialysate bath (see figure 4l). Supplying 
dialysate fluid at the flow rate of 700 ml/min is pumped out
from a 70 liter reservoir to the well mixed dialysate bath
and then flows into the reservoir for a closed loop.
A detailed description of two pieces of equipment shown 
in Figure 42 is as follows:
Dextrose Metering Pump: This pump is manufactured by
Cobe Laboratories Inc., Lakewood, Colorado. The flow rate 
can be adjusted from 0 to 8.5 ml/min.
Well Mixed Dialysate Bath (see figure 40): This is a
600 ml container. For getting well mixed dialysate flow 
geometry, the magnetic stirrer with a 1" Teflon mono-mold 
magnetic stirring bar in the bath and high dialysate flow 
rate, 700 ml/min, are used in these experiments.
The concentration measurements are read from the opti­
cal density for vitamin and counting the radioactivity
14intensity for C -creatinine in these experiments. Here, 
spectrophotometer is chosen for the former and liquid 
scientillation system is used for the latter. Their detailed
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descriptions are as follows:
The Spectrophotometer is a Beckman model 24 manufac­
tured by Beckman Instruments Inc., California. The wave 
length for operation in visible range is from 340 to 370 my. 
It is set on the wave length of 361 my for vitamin B ^  
from 0*100 to 2.000. But for quantitative analysis, the 
concentration of the sample solution should be such that the 
absorbance reading is in the range of 0.3 to 1.2. In this 
range the. analytical accuracy is optimized.
The Liquid Scientillation System is a Beckman model LS- 
100 manufactured by Beckman Instruments Inc., California.
A 1 ml sample is taken and put into 10 ml TX-100 Scientilla- 
tion*cGcktail mixture® for counting the intensity of radio­
activity. Other operation conditions are as follows:
c
A. Present error selector: Set on 0.5$ for carbon-14
counting.
B. External standard ratio: About 12.0
C. Present time: 50 min.
D. Low sample reject selector: 20 cpm.
E. Action controls: Single cycle.
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TECHNICAL PROCEDURES
A. Examination of Hollow Fiber Bundle for Structure Defects 
and Leak Test
1. Visually examine both ends of the bundle and fibers 
for debris or other structural defects.
2. Examine tube sheet under a stereoscope for irregu­
larities in surface finish.
3. Connect the pressure„test unit (PTU) to one blood 
end of the bundle and force any fluid in the fibers out.
c •
4. Clamp another blood end of the bundle and submerge 
it in the RO/DI H20 bath (37°C ± 0.1°C).
5. Pressurize one end of the bundle to 300 mmHg with 
PTU. }
6. Examine the fibers and potting heads for leaks.
Fiber leaks and potting leaks can be observed from the 
appearing bubbles and decreased pressure.
7. Fiber leaks, less than five, should be fixed (stopped) 
by fire or heated pincers. (Having fiber leaks more than 
five, the bundle is not used in these experiments.)
B. Degassing Hollow Fiber Bundle
1. Preparation for the static ultrafiltration coeffi­
cient test —  using syringe.
a. Connect each head of the bundle to one liter RO/DI 
H20 bottle and 50 ml syringe respectively.
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b. Quickly suck the fluid by using the syringe and
then pressurizing it. Avoid the gas entered into 
the fiber.
c. Repeat above procedure at least three times until
no bubbles occur.
2. Prepare for the overall mass transfer resistance 
test —  using roller pump (Dextrose Metering Pump).
a. Connect the bundle with the dialysate container which
is connected to the roller pump.
b. Turn on the roller pump and set at maximum flow rate.
c. Clamp and release the outlet of the tube from blood
head of bundle alternatively until no bubble goes 
out.
C. Determination of Hollow Fiber Static Ultrafiltration 
Coefficient
1. Degas the bundle with fresh RO/DI H^O.
2. Submerge the bundle in a RO/DI H^O bath (37°C t 0.1°C) 
and allow 10 minutes for temperature equilibrium.
3. Connect a burette filled with fresh RO/DI H^O to one 
blood head of the bundle and clamp off the other blood head.
4. Connect the burette to the PTU and pressurize to a 
fixed pressure and record the reading of the manometer.
5. Turn on the connector and let the fluid (RO/DI H^O) 
ultrafiltrate from the porous membrane. Record the time 
needed for ultrafiltration 0.2 cc fluid.
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6. Repeat the above measurement three to five times 
and then take the average value of ultrafiltration time.
7* Measure the hydrostatic pressure from the level of
0.1 cc mark in the burette to that of the bundle.
8. Do the appropriate calculation to get the ultrafil­
tration coefficient.
D. Determination of Hollow Fiber Overall Mass Transfer 
Resistance (or Coefficient)
1. Blood solutions are prepared by dissolving a given 
amount of compound (creatinine or vitamin in this inves­
tigation) in saline. Sodium chloride solution (0.9 gm$) is 
used to make the dialysate Isotonic and the same osmolarity 
as the blood side. The blood solution is kept in the RO/DI • 
H20 bath (37°C ± 0.1°C). The dialysate solution (0.9 gm% 
NaCl) Is pumped from a big tank (70 1) to a well mixed dialy­
sate bath (see figures 40 and 42). The big dialysate tank
is kept at 37°C t 0.1°C using a thermostat (Thermomix). The 
well mixed bath is a container with a magnetic stirrer.
2. Connect the bundle to the above well mixed dialysate 
bath and turn on the switch of the micropump to fill the 
well mixed dialysate bath with fluid.
3. Degas the bundle with saline by using roller pump 
and hemostat until no air builds up in the venous head.
4. Set the roller pump to have the blood flow rate at 
approximately 2 cc/min.
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5. Measure the time needed for flowing 9 ml blood fluid 
and calculate the exact blood flow rate.
6. Adjust the micropump to have the dialysate flow rate 
as high as possible. In this investigation the dialysate 
flow rate is set for 700 ml/min.
7. Turn off the switch of roller pump and put the pip­
ette of artery end into blood solution bottle.
8. Turn on the switch of roller pump and wait 10 min.
for equilibrium.
9. Take 5 ml sample from the venous end, the artery 
blood bottle and the dialysate-out respectively.
10. Measure the optical density for vitamin and
14count the radioactivity intensity for C -creatinine for 
each sample.
11. Perform the appropriate calculation to find the 
overall mass transfer resistance, Ro (or coefficient, Ko).
T 1765 113
RESULTS
A. Evaluation of PAN Fibers
1. Static ultrafiltration coefficient—  The blank
test data from 12 bundles give the range of static ultra-
2filtration coefficient from 2.02 to 3.22 ml/hr/mmHg/m . Its 
average value is 2.42 ml/hr/mmHg/m . After running blood, 
the static ultrafiltration coefficient is reduced and ranges 
from 0.72 to 1.34 ml/hr/mmHg/m for these twelve bundles.
The average value is 1.05 ml/hr/mmHg/m . Table B-l shows 
all these values of blank test and blood test (Appendix B).
2. Overall mass transfer resistance —  Except for one 
high value (1100 min/cm), all other 11 bundles show that the 
overall mass transfer resistances for vitamin B-^ range from 
317.0 to 677.8 min/cm in the blank test. After running 
blood, the previous values increase and range from 436.2 to 
1177.7 min/cm (except for one high value, 1729.5 min/cm). 
Except for bundle A2C the creatinine permeability data give 
the values of overall mass transfer resistance from 74.2 to 
186.3 min/cm in the blank test. After the blood test, all 
these values increase and range from 107.0 to 178.8 min/cm 
except for two high values (317.0 and 303*9 min/cm). Table 
B-2 and B-3.give the mass transfer permeability data for 




1. Static ultrafiltration coefficient —  After running 
blood, the static ultrafiltration coefficients Is decreased 
by 57.5$ for 12 bundles (see Appendix B, Table B-l).
2. Mass transfer resistance —  After the blood test 
the overall mass transfer resistance of the 12 bundles is 
increased by 90.3$ for vitamin B ^  and 40.8$ for creatinine 
(see Appendix B, Table B-2, B-3).
C . Albumin Effect
1. Static ultrafiltration coefficient —  After running 
albumin, the static ultrafiltration coefficients is decreased 
by 52.8$ for 3 bundles (see Appendix B, Table B-4).
2. Mass transfer resistance —  The overall mass trans- •
o
fer resistances of 3 bundles increased 44.7$ for vitamin 
B-̂ 2 and increased 32.0$ for creatinine because of the albu­
min effect (see Appendix B, Tables B-5 and B-6).
©
D. Hemoglobin Effect
1. Static ultrafiltration coefficient —  Owing to the 
hemoglobin effect, the average percentage change of static 
ultrafiltration coefficient is -57.9$ for 3 bundles (see 
Appendix B, Table B-7).
2. Mass transfer resistance —  Hemoglobin affects the 
overall mass transfer resistance, and increases an average 
value from 3 bundles of 49.3$ for vitamin B-^ and 31.9$ for
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creatinine (see Appendix B, Tables B-8 and B-9).
E. Dextran (M.W. = 66,900) Effect
1. Static ultrafiltration coefficient —  Dextran test 
shows that after running dextran, the static ultrafiltration 
coefficients is decreased by 15.8# (average value from five 
bundles data) (see Appendix B, Table B-10).
2. Mass transfer resistance —  After running dextran
for 3 bundles, the overall mass transfer resistance is
decreased by 17.9# for vitamin B-. « and 10.4# for creatinine * ' -L*-
(see Appendix B, Tables B-ll and B-12).
P. Deoxyribonucleic Acid (DNA) Effect
1. Static ultrafiltration coefficient —  Experimental 
data shows that decreasing 29.7# in static ultrafiltration 
coefficient after running DNA test for 3 bundles (see 
Appendix B, Table B-13).
2. Mass transfer resistance —  The overall mass transfer 
resistance decreases 22.1# for vitamin B ^  and 8.3# for 
creatinine after DNA test for 3 bundles (see Appendix B, 
Tables B-14 and B-15).
G . Sodium Hypochlorite Effect
1. Static ultrafiltration coefficient —  In blank test, 
the 0.525# sodium hypochlorite solution affects the membrane 
and decreases the static ultrafiltration coefficient 39.8#
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In these five bundles tests (see Appendix B, Table B-16).
2. 'Mass transfer resistance —  In blank test, the over­
all mass transfer resistance Increases an average value of 
86.2# for vitamin B^2 and 9^.7$ for creatinine In 6 bundles 
tests of treating with 0.525# sodium hypochlorite solution 
(see Appendix B, Tables B-17 and B-l8).
H. Hydrogen Peroxide Effect
1. Blank test:
a. Static ultrafiltration coefficient —  The result of
5 bundles tests shows that the static ultrafiltra­
tion coefficient decreases 31.9$ after treating 
with 3.0# hydrogen peroxide solution (see Appendix 
B, Table B-19).
b. Mass transfer resistance —  The average percentage
change in 6 bundles tests for the overall mass
transfer resistance is -6.6# for vitamin B ^  and 
-3.9$ for creatinine after treating with 3.0#
#2® 2 solution (see Appendix B, Tables B-20 and 
B-21).
2. Reuse test:
a. Static ultrafiltration coefficient —  The treatment 
of 3.0# solution (after blood) increases the
static ultrafiltration coefficient 6.9$ in 9 
bundles tests (see Appendix B, Table B-22).
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fe* Mass transfer resistance —  The effect of 3.0#
^2^2 ^a^ er blood) on the membrane is to Increase 
the overall mass transfer resistance 18.7# for 
vitamin and 3.7# for creatinine in 9 bundles
tests (see Appendix B, Tables B-23 and B-24).
I. Reverse Pressure Effect
1. Static ultrafiltration coefficient -- The average 
increase of percentage in 3 bundles tests for the static 
ultrafiltration coefficient is lH.6% (see Appendix B, Table 
B-25).
2. Mass transfer resistance —  The average increase 
for .reverse pressure treatment in overall mass transfer 
resistance is 2.3# for vitamin B ^  and 8.5# for creatinine
e
(see Appendix B 3 Tables B-26 and B-27).
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ERROR ANALYSIS
A. Error From the Membrane
1. The Inside diameter has a large range from 200 ym to 
260 ym. This value Is measured from microscope. The meas­
urement Is just approximate evaluation. The average value 
is not taken from all 150 measured data. Only 5 fibers are 
measured and from which the average Is taken. This evalua­
tion of the Inside diameter gives the main error of calculat­
ing the overall transmembrane area which induces an error in 
the overall mass transfer resistance and static UPR.
2. The thickness of the hollow fibers is assumed to 
have the same value in evaluation the static UPR and Ro of 
the fibers. But, the thickness of fibers is different from 
each other. The thicker the fiber, the higher the value
of Ro.
3. The pore size and size distribution is assumed to 
have the same average value in each bundle. Prom the tech­
nique or manufacture viewpoint, there are many different 
pore sizes in a membrane. The manufacture condition, such 
as temperature, pressure, moisture, catalyst, or the type 
of plasticizer will affect the pore size and its distribu­
tion in a membrane. This is one of the reasons why the 
bundles show a large range of static UPR and Ro.
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B. Error From Time Effect
The binding between protein and membrane or blood and
membrane are believed to tighten with time. Although the
bundle is rinsed with saline at once after running blood or 
protein, the protein-membrane binding may change with the 
storage time.
C . Error From the Protein Denatured by the Formaldehyde
The bundle is stored in 0.02% formaldehyde solution.
The reaction between protein and formaldehyde will let the 
protein denature. The denatured protein binding with the 
membrane may change the character of mass transfer permea­
bility.
D. Error From the Gas in Fibers
The gas in fibers will stop the blood flow. Complete
degassing can be reached and observed in the measurement of 
static UPR. But the gas in fibers cannot be observed dir­
ectly in the measurement of Ro. Clamping and losing the 
tube sometime does not degas completely for small fibers. 
This will reduce the effective fibers and reduce the total 
transmembrane area which affect the calculation of Ro.
E. Error From the Manufacture of Bundle
When a bundle is potted, some fibers may be constricted 
too much. There is no blood flow or very slow blood flow
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rate in these constricted fibers. This will reduce the number 
of effective fibers and have the error of the overall mass 
transfer permeability and the static UFR.
F. Error From the Blood Flow Rate Measurement
The blood flow rate is measured from the time needed for 
taking 9 ml blood flow to minimize the error of observation. 
But the error of the roller pump itself and the error from 
the loosening of the tube in the roller pump in an experiment 
may be caused by a significant error for measuring Ro.
G. Error From the Temperature
«, The water bath is kept at 37°C t 0.1°C. Within this 
range, small error is still caused by the change of tempera-- 
ture for static UFR test. The reservoir is kept 37°C t 0.1°C, 
but the temperature of a well-mixed dialysate container 
should be lower than the reservoir. The high dialysate flow
e
rate will minimize the temperature difference between the 
reservoir and the well-mixed dialysate container. But it 
will cause the error from the temperature in measuring Ro.
H. Error From Pressure
When fluid is ultrafiltrated from the membrane, the 
transmembrane pressure is changed. An average value is 
taken. But the error caused from the reading of pressure 
and/or from the pressure gauge itself will affect the static 
UFR.
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I . Error From the Instrument for Measuring the Sample
The Instruments for measuring the optical density and 
counting the intensity of radioactivity of samples can cause 
some errors which affect the static UFR or the Ro.
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DISCUSSION OF RESULTS
The error analysis indicates that there are many 
factors affecting the results in this investigation and 
therefore a statistical analysis is needed. For the samples 
less than 30, student t distribution was used for the sta­
tistical analysis. Because of the differences among bundles, 
the change of percentage was chosen for this analysis. If 
t and y represent the computed t value and the mean, the 90$ 
of t tests for biochemicals show the results as follows:
1. Blood membrane effect on the static UFR —
a. t (22.4) >
b. -62.1$ < y < -52.9$
2. Blood membrane effect on the Ro of vitamin B ^  —
b. +29.2$ < y < +52.4$
4. Albumin membrane effect on the static UFR —
a. t (17.59) > tQ>05
b. —6l.6$ < y < —44.0$
5. Albumin membrane effect on the Ro of vitamin B ^  —
a. t (5.03) > tQ .o5
b. +58.1$ < y < +122.6$
3. Blood membrane effect on the Ro of creatinine
a. t (6.31) > t0 .05
a. t (6.51) > t0 _05
KRT' 
COL'- • • 
gold :
b. +24.6$ < y < +64.8$ S
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6. Albumin membrane effect on the Ro of creatinine —
a. t (4.33) > tQ 0 5
b. +10.4$ < y < +42.6$
7. Hemoglobin membrane effect on the static UPR —
a. t (14.33) >
b. -69.7# < y < -46.1$
8. Hemoglobin membrane effect on the Ro of vitamin
a. t (3.85) > t ^ Q5
b. + 1 1 . 9 %  < y < +86.7#
9. Hemoglobin membrane effect on the Ro of creatinine —
a. t (3.73) > t0>Q5
b. +7.0$ < y < +56.9$
10. Dextran (M.W.=66a900) membrane effect on the static UPR —
a. t (2.42) > tQ>05
b. -29-1% < y < -1.9#
11. Dextran (M.W.=66,900) membrane effect on the Ro of
e
vitamin B-^ —
a. t (2.58) > tQ>05
b. +3.1% < U < +32.7!?
12. Dextran (M.W.=66,900) membrane effect on the Ro of 
creatinine —
a. t (2.04) > tQ>05
b. -0.5% < V < +21.3!?
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13. DNA membrane effect on the static UFR —
a. t (4.68) > tQ
b. -48.3# < y < -11.2#
14. DNA membrane effect on the Ro of vitamin B —
a. t (3.99) > tQ>05
b. +5.9$ < y < +38.3$
15. DNA membrane effect on the Ro of creatinine —
a. t (2.11) < tQ>05
b. -3.2# < y < +19.8#
The 95$ of t test for chemicals and reverse pressure 
treatments show the results as follows:
1. Sodium hypochlorite membrane effect on the UFR —
a. t (4.59) > ^0.025
b. -63.9$ < y < -15.7#
2. Sodium hypochlorite membrane effect on the Ro of 
vitamin —
a. t (2.92) > tQ ^025
b. +10.4# < y < +161.9$
3. Sodium hypochlorite membrane effect on the Ro of 
creatinine —
a. t (3.56) > t0>025
b. +26.3$ < y < +163.1$
4. Hydrogen peroxide membrane effect on the static UFR
in blank test —
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b. -45.135 < V < -IS.7%
5. -Hydrogen peroxide membrane effect on the Ro of 
vitamin blank test —
a. t (1.24) < t0 ^025
b. -20.2% < u < +7.0%
6. Hydrogen peroxide membrane effect on the Ro of 
creatinine in blank test —
a. t (1.00) < t 0>Q25
b. -14.0% < u < +6.2%
7. Hydrogen peroxide membrane effect on the static UFR 
after blood test —
a. t (1.53) < ^0.025
b. -3.535 < u < +17.3$
8. Hydrogen peroxide membrane effect on the Ro of 
vitamin B.^ after blood test —
a. t (2.24) < tg.025
b. -0.6% < u < +38.0%
9. Hydrogen peroxide membrane effect on the Ro of 
creatinine after blood test —
a. t (0.75) < t0 .025
b. -1 .1% < u < +15.1%
10. Reverse pressure membrane effect on the static UFR 
after blood test —
a. t (2.16) <
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b . —14.556 < p < +43.7$
11* Reverse pressure membrane effect on the Ro of
vitamin B after blood test
b. —11 . 656 < y < +16.25?
12. Reverse pressure membrane effect on the Ro of
creatinine after blood test
a. t (3*27) < ^0.025
b . -2.7$ < y < +19.7$
According to the t distribution analysis, there are four 
groups of membrane effects. These are as follows:
1. All the changes of the static UPR and the Ro of
c
vitamin and creatinine are significant —  blood, hemo­
globin, albumin, and sodium hypochlorite solution.
2. The changes of the static UPR and the Ro of vitamin
Big are significant, but the change of the Ro of creatinine
is not significant —  DNA and dextran (M.W. = 66,900).
3. The change of the static UPR is significant, but the 
changes of the Ro of vitamin B ^  and creatinine are not 
significant - hydrogen peroxide in blank test.
4. All the changes of the static UFR and the Ro of
vitamin B ^  an<3 creatinine are not significant —  hydrogen,
peroxide solution and reverse pressure treatment after blood 
test.
T 1765 127
All 27 tables In Appendix B can be analyzed with a t 
test and condensed In Table 4, which shows the results of 
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CONCLUSIONS
1. The data of static ultrafiltration coefficient (UFR) 
and overall mass transfer resistance (Ro) of PAN fibers show 
that PAN appears to be a good choice as a membrane for an 
artificial kidney system.
2. The Increasing Ro and decreasing static UFR for sev­
eral different compounds show that some biochemical compounds 
are binding or Interacting with the membrane.
3. The Increasing Ro and decreasing static UFR with 
albumin and hemoglobin are close to those of blood test Indi­
cate that proteln-membrane binding is the main mechanism to 
decrease the solute transfer.
4. Biochemical compound-membrane binding appears to be . 
more significant for macro molecules than for small molecules 
(urea and creatinine).
5. The membrane effects on static UFR and Ro of these
odifferent compounds are as follows,, in descending order:
a. Protein (hemoglobin and albumin) and blood.
b. Deoxyribonucleic acid (DNA).
c. Dextran (M.W. = 66,900).
6. The membrane effects on the Ro of small molecules 
(creatinine) is not significant for dextran (M.W. = 66,900) 
and DNA.
7. Sodium hypochlorite solution interacts with the PAN 
membrane which decrease the static UFR and increase Ro.
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For this reason, sodium hypochlorite solution Is unsuit­
able for reuse of a PAN dialyzer.
8. The treatment before blood test (blank test)
decreases the static ultrafiltration rate but there Is no 
significant change In the mass transfer permeability of 
vitamin an<3 creatinine for this treatment.
9. There Is no significant change In the static UFR and 
the Ro (vitamin and creatinine) for the treatment 
of this PAN membrane which Is tested after blood.
10. The reverse pressure treatment does not Improve the 
* *
static UFR and the permeability of this PAN membrane under 
Investigation after blood treatment.
Subsequently, this technique Is being used on the DOW-4 
dialyzer at El Camlno Hospital (54). The utilization of the 
technique was arrived at Independent to this Investigation.
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HECOMMENDATIONS
1. The membrane effects of,other middle or large molec­
ular weight biochemicals in the blood (such as cholesterol or 
globulin) may provide more information about the membrane 
effects found in this investigation.
2. Evaluation of reuse treatments: Other chemicals (such 
as sodium peroxide) may be used to evaluate the possibility
of reusing the PAN membrane.
3. Time effect (biochemical-membrane binding with time) 
and the change of pH should be investigated when these experi­
ments are continued.
4. To minimize the error from heterogeneity of the mem­
brane, more fibers in each bundle and using fibers having a 
smaller range of inside diameter and thickness are needed.
5. A bundle can be tested with different flow geometries. 
About 600-800 fibers placed in a small case becomes a mini- 
dialyzer and can be tested with countercurrent or co-current 
flow geometry. The data from mini-dialyzer (1/10 of full scale 
dialyzer) would yield better data in measuring the overall 
mass transfer resistance.
6. By keeping a negative pressure in the dialysate side 
(using a pump to apply negative pressure from the dialysate 
outside), a mini-dialyzer or full-scale dialyzer can be tested
the flow ultrafiltration rate . The flow ultrafiltration rate
T 1765
is calculated from the ultrafiltration time, ultrafiltration 
weight, fluid density, and transmembrane pressure.
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Derivation of Overall Dialyzer Mass Transfer 
Relationship for Three Plow Geometries in 
Three Different Methods of Dialysis
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Derivation of Overall Dialyzer Mass Transfer Relation­
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c. Well Mixed Dialysate Flow Geometry 
Figure A.1• Diagram For Different Flow Geometry
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The differential form of mass transfer is shown as 
equation (A.1) through differential area, dA. (see figure 
A.1 ).
where Cg and Cd are concentrations in blood and dialysate 
phase and dN is mass transfer rate through the differen­
tial area.
The overall mass transfer coefficient in terms of 
flow rate, Q, area and concentration can be derived for 
different dialysis methods and different flow geometries.
A. Dual Single Pass:
1. Countercurrent flow geometry: In this flow ge­
ometry, the differential equation for mass transfer rate 
is written as equation (A.2) with constant blood and 
dialysate flow rates, Qg and
dN = K0 ( CB - CD ) dA (A.1 )
dN = - Qg d CB = - Q d  d Cq (A.2)
where dCg and dCg are differential concentrations which 
mean the blood and dialysate concentration difference 
between left side and right side in a differential area,
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dA. The negative sign in the equation is set for keeping 
both sides positive in mass transfer (see figure A.1.a) 
After rearrangement, one obtains:
dN   Qd d Cq  = - Qb d Cd (A.3)Qd Qd
Q tjdN - dN = QB d Cd - Qb d CB (A.it.)
dN = -  qb ■* .(. ° B -  .°S )■. ( a . 5)
1 Qb
Qd
Combining equation (A.1) and equation (A.5), one 
obtains:
( C C \
- Qb — B P "■ = K0 ( CB - CD ) dA (A.6)QB
Qd
or
" V c  B ~r V  = - K° (  fer } dA (A*7)( Cg - Cjj ) Qb Qd
If the membrane is homogeneous, the average overall 
mass transfer coefficient should be constant. After in­
tegrating across the membrane, one obtains:
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J CB„_ CDr d ( CB - CD ) _ „ ,  1_CB^“ CD, ( Cb * CD ) ° Qb %  j o dA
(A.8)
where
Cg. and Cr are inlet and outlet solute concentrationi o
in blood phase.
Cjy. and Cp are inlet and outlet solute concentration 
C °
in dialysate phase.
In ’ CB. - CD/, CB- - CDo = - Kq ( % QD ) A (A.9)
or Kq  = - Qb
a  (i - -2s_>
In
Q d
CBo - CD I
Cb  ̂ - Cd 0
(A.10)
According to the definition of mass transfer rate and 
mass balance, the mass transfer equation can be shown as:
N = Qb < °b -l - cB ff ) (A.11 ) 
(A.12)
i.e. N
CB; “ CB (A.11 1 )




Qb = Cp„ - Cpi 
Qd Cp^ - Cp̂ (A.13)
Substituting equation (A.111), equation (A.13) into 
equation (A.10), one obtains:
N
KnA = CB /. " cp g






CB; “ Gp _
After rearrangement, one obtains:
(A.II4.)
( B„ - D/, ) - ( B /. - GP c )
In CB Cd ;cb c d ,
(A.15)
= KoA ( A C  )1 (A.16)
where ( a U  )-j represents the logarithmic mean concentration 
driving force in a countercurrent flow geometry and is de­
fined as:
( A C  )1 = ( °B, '•d ; ) - ( CB / - CD




The definition of dialysance, Dp, can be represented 
by the following equation in a constant Qp and Qp:
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Db . -°BL-Z CB,_ Qb = CD„  Z ^ P i  Qd (A.i8)
■ CB - - CD . CB. - CD ^
Dividing Qg or Qg, one changes equation (A.18) to:
dB CB/ - CB (




CDo - CD/. 





,b 0 - gd ;
'B; -  GD
(A.21 )
1 . -£B_ = J f e  (A.22)
Qd °b  ̂ -
Dividing equation (A.21) by equation (A.22), one 
obtains:





1 - d b
(A.23)
Qd
Substituting equation (A.23) into equation (A.10), one 
obtains the following equations showing the relationship 





d b = Qb
1 - . Qb exp - KoA ( 
Qd
(A* 25)
2. Cocurrent flow geometry: With constant Qg and Qg^
equation (A.2) should be changed to equation (A.17) in 
this flow geometry.
The sign difference here is due to the direction of 
flow and intergrating area which is from the left side 
to the right side (see figure A.1.b). The minus sign in 
equation (A.26) becomes positive mass transfer rate.
Following the same derivation procedures as those in 
countercurrent flow geometry, one obtains a equation of 
K 0 which is in terms of A, Qg, Qd , Cg , Cg , Cg , and Cg . 
The main equation are shown as:
dN = - Qg d Cg = Qg d Cg (A.26)





d ( CB - CD )
'B
= K0 ( CB . CD ) dA (A.28)
Bo d ( Cg - Cp )
CB . -  CD;G 0
cB - CD K0 ( — —  + — -—  )/ dAQb Qd t/o
( a . 29 )
In c3„ - CD,
cB . - CD .
= - Ko (
Qb Qd ) A (A.30)
K = - Qb
A ( 1 + Qb
In
Qd
cb, - cDo 
L  c B /  - cD
G G
(A.31 )
Substituting equation (A.11f) and equation (A.13) into 
equation (A.31 ) and after rearrangement, one obtains:
N = K0A ( -  C p J  -  ( CB /  -  CD ; )
ln [ < CSq - CP* >
L ( CB . -  CD . ) J
(A.32)
= K A ( JTT ) (A.33)
where ( hC )z represents the logrithmic mean concentra­
tion driving in a cocurrent flow geometry and is defined as:
< zrr )a - ( CB„ - CD„ ) " ( CB I ~ cDi )
ln ( CB„ - Cp, )
. ( CB, -
( A . 3 4 )
Combining equation (A.19) and (A.20), one obtains:
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cs „ — Cp„
c B - -  CD .
=  1 -
D_B
Qb ( 1 +
Qg
Qd (a .35)
Substituting equation (A.35) into equation (A.31), one 
obtains the following equations showing the relationship be­
tween Kq and. Dg.
k = - Qb
A ( 1 + Qb
Qd
In 1 - DB











3. Well mixed dialysate flow geometry: In this flow geom­
etry, the concentration of dialysate side is kept constant
c
(Cd0 = constant) (see figure A.I.c). The derivation proce­
dures of Ko is semilar to those in the two previous flow ge­
ometries, The main equations and the mass transfer coeffi­
cient, Kq , in terms of Qg, A, Cg., Cg and Cdd are shown as:
L
dJT = K0 ( Cg - CDo ) dA
dN = - Qg d Cg
(A.38)
(A.39)
Ko ( Cg - Cg ) = - Qg d Cg (AJ+O)
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d ( cB - cDfl )_ = _ ^  ( _ j _  j dA
CB - Cn Qb (A.1*1)




d ( cB - CD )
C D 0 CB -  ° Dn
CBo -  cD„ 1
=  -  Ko
1
CB . -  C D „  J Qb
= - Kq ( Qb
A
)/ dAo (A.I4.2 )
or
Qb In CB.-CPo
°Bl - CD. (A • I4I4.)
Substituting equation (A.11*) into equation (A.I4J4-) and 
after rearrangement, one obtains:
N =  K o A
- Cn ).2---- ----------
In
-‘'O
r  ° b ?  -
'------------
°.Qa_]
L  c B £  - c d „  J
( A . k 5 )
=  K o A  ( A C  )3 ( A . l + 6 )
where (A C  ^represents the logarithmic mean concentration 
driving force in a well mixed dialysate flow geometry and is 
defined as:
( A C  )3 = ( cb„ - CDo ) - ( CB ,; - CDr )
In C B n ~ C p^CB . - D̂.
(A.1̂ 7)
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The three logarithmic mean concentration driving forces 
in equation (A.17), equation (A.34) and equation (A.47) are 
different form. These differences are due to the flow di­
rection in the first two cases and the constant dialysate 
concentration in the last case.
Dividing equation (A.35) by equation (A.22), one obtains
CBo - CDo
- °D0 D1 B
(A.48)
Qd
Substituting equation (A.48) into equation (A.44)* one 
obtains the following equations showing the relationship 
between K0 and Dg.
QbK0 = - — r- In
D




Qd ) (A. 49)
or
d b = Qb
1 + i n
Qd
exp ( -







B. Closed loop in blood side and single pass in 
dialysate side:
Total solute mass, (M) , in blood phase is represented 
by the following equation:
M = VB CB (A. 51)
Where VB is total closed loop blood volume. In 
vitro (outside the organism), it includes the dialyzer 
blood volume, the tubing set volume and the blood volume 
in a container (flask),(see Figure 24.) In vivo (inside the 
organism), it includes the first two kinds of volume (as in 
vitro) and the patient's or experimental animal's blood 
volume (see Figure 24).
Taking the differential form of equation (A. 51), one 
obtains:
M = -N = Vn + cB (A. 52)B dt B dt
Under the assumption of no ultrafiltration, VB remains
dV]
dt
Rthe same amount during an experiment. It means — £1 is
zero or is negligible.
N = -V„ — ^  (A - 53)B dt
The minus sign in equation (A. 53) is for both sides 
of the equation keeping positive.
Equation (A. 11), eq. (A. 12), eq. (A. 15), eq. (A. 32) 
and eq. (A. 45) are suitable in this case for certain 
instances. This is because in dual single pass, Cg^, CBo,
CDi and CDo are constant after equilibrium, then N is constant
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In blood closed loop, all the concentrations except CDi 
are functions of time. Therefore, N is changable with 
time.
1. Countercurrent flow geometry:
Combining equation (A. 53) and equation (A. 15), 
one obtains:
-V = K0A (CBo“CDi* “ (CBi”CDo) (A. 54)
dt ---- ——----------------
S,n r Bo ~ cDi1
cBi " cDo
From the concentration difference, one gets 
the following two equations.
c _ _ VB dCB (A. 55)
BO Q b  dt
c D i  =  X e  £ £ o  <A - 5 6 >
Qp dt
o
The mass balance equation is shown as:
VBdCB = ”vDdcD (A* 57)
Substituting equation (A. 57) into equation (A. 56) 
on obtains:
CDo - CDi = - ^  ^  <A - 58>
Q d  d t
Substituting equation (A. 58) and equation (A. 57) 




After rearrangement, equation (A. 59) is changed 
to:
<CBi - CDi) + Zl ££b 
In [  °B —  ] = -K„A-( | ---- 1 ) (A. 60)
(CBi - CDi> - ^  ^Qd dt
VB dCB
<cBi “ cDi> + QB dt q _ Q---------------    = EXP [-KoA (Ha__ Hi) ] (A. 61)
(Cb i - cDi> + Za HHa Qb Qd
Qn
After rearrangement, one obtains
Qd ” qbdCB _ (CBi - CDi) EXP [-KoA ( ^ —
dt





If the blood volume of the container (in vitro 
case) or the patient's (or animal's) blood volume (in 
vivo case) is much larger than the dialyzer blood 
volume, CB is close to CB-j_ for a short time. Then 
equation (A. 62) can bf. represented as:
d(CBi ~ CDi) _ QbQd  ̂  EXP [-KqA (QP~°B)1 - 1 /
o»4 -  c n4  J   HbQd_______1Bi ~ uDi ----- ‘------------------------- * dt (A. 63)
v b  { q d  - q b  e x p  [_k o a  ( S a l H i ) i I
( ^D^B J
Where inlet dialysate concentration, CD^, is constant 
in this case. Integrating from time 0 to time t, one 
obtains:
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(CBi - ® D i U
(CBi~ CDi^o
152
d <CBi - CDl> _ QE %  f EXP
CBi-CDi
f-KnA (QD‘Qb) - 1
QBQD . J
VB Q„-Qd EXP f-KnA (QD~QB )‘D B I 9B9D3Udt
Where and are concerrfcra‘t*on difference
between blood in let and dialysate inlet at time t and time 0, 
i • e •
^ b I-Cd 1)o " B D
QcQo< EXP
9B9D j
'B Qd-Qd EXP l~-KnA (*D~['
IXS8P)
After rearrangement, one obtains
+ VB lnEXP [-KoA (QD~QB )] = 1 +
V b I + VB In
or













After rearrangement one obtains 1
B ln 
t“
^CBi"CDi^o 1-EXP -K,3a  (q d ~q b ) 
q d 9b ->
1-qB e x p -K^A (QD-QB)







Substituting equation (A-68) into equation ( 51), one 
gets the following equation showing the relationship between
and in this cases o . D
r ®n-®b'1 - EXP [-KoA H j ^ ) , (A-69)
1 - 2 ®  EXP 
Qr,
-Kr,A ( % % '
V b j
2. Concurrent flow geometrys
Using equation (A -32)* equation (A-53)» equation (A-5$) 
and equation (A-55) and following the same derivation pro­
cedures as those in above flow geometry, one gets the main 
equations as followss
(A-70)-V_ dCB * K0A (CBo“CDo^ " ^CBi”CDi^ 
® “cTE' “In CBo~CDo"
_CBi~CDi.
From equation (A-55) and equation (A-58), C^0 and CBo* 









Substituting CBq and CDq shown in above two equations 
into equation (A-68) one obtainsi
" (CBi"CDi*v dCB « KoA 
B W
VB BCB(C..+ IS. dCB s _ ( n  — . D \
®^ QB ^  ^
ln r (CBi+lB 22b )- (Cn4-^B 22b > 1




After rearrangement, one gets equation (A-74), 
equation (A-7S) and equation (A-76).
154
ln
VB dC(0D+ QtO B'Bi_ Di' ' Qb Qd 'v;b' "d' dt 
CBi " CDi
= -KqA (Q_ + Q_ B (A-74)
1 ' dCBi ( 11 + VB (5-  + 5 - )  ( __1  ) = EXP [-KqA (i- + i-) ] (k-lS)qb qd d t  c!B i - c D i  0 q b  Q d
d (cBi_cDi^ QbQd QR+QnEXP [-K„A( „ „ ) ] -1 dt (A-76)CBi-cDi V b (Qb+Qd) 1 “o"' QnQn








ln q b q dv b (Qb+Qd )
K = - QB
A(1+SB)
ln < VR Qrj
1+(d } (1+^ } ln











After rearrangement, one obtains: \
(CBi CDi^ t QBQD < e xp
'-KoA(Qb+ QD r -1 \
ln q b q d(CBi“CDi) 0 (Qb +Qd ) ✓
( A - 8 0 )
Substituting equation (A-80) into equation (& 1) , one 
gets equation (A-8I) which shows the relationship between 







K0A Qo1-EXP [-(-g-) (1+ B} ]
B Qd ( A - 3 f )
3. Well mixed flow geometry:
Using equation (A-4 6) instead of equation (A-15) 
in countercurrent flow geometry, and following the same
derivation procedures, one obtains:
dC
-VB dtB = KqA
, _ , Vd dC-Q(CBi+_B _ B  ) - C
Qb dt Bi (A -$2 )
In
VB dCB VB £^B
(CBi+QB dt ’ “ <CDi" %  dt 
Vb ^ b  .- ^Bi ” (Cni ■ )'D1 Qd dt
After rearrangement, equation (A-59) and equation 
(A-60) are shown as:
In
Q+Q_ dCo
(CBi-CDi) + V ^ b r ’__________________~~B D_____
Vn dCL  (cB i - c D i ) + ^ B B








QBQD(CBi-CDi) tEXP > "I!
-----------------------Qb-------
v QD-QB tEXP (“
KnA )-l]
Qb
Intergrating above equation, one obtains:
‘*CBi“CDi* t
d ĈBi CDi^ =
(CBi CDi^ 



















= B In QB (CBi"CDi)o












QB ^ 7 71 + [1-EXP (5--) ]Qn B
(A-88)
Substituting equation (A-88) into equation (51), 
one obtains the equation of DB in terms of K0 , QB , QD 
and A:
KqA
Qb [1-EXP(-  -- )]
d b “ -B
1 + lB [1-EXP Qb
(A-83)
) ]
C. Dual Closed loop:
Under the same assumption as the above cases, no 
ultrafiltration, the derivation for dual closed loop can 
be followed in those equations from equation (A-51) to 
equation (A-62). But the term of logarithmic mean con-
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centration driving force, (AC)n , should use the suitable 
term in equation (A-15)., equation (A-32) and equation 
(A-45) for the different flow geometries.
The total mass balance equations are set as follows:
M = CBi° VB + CDi° VD (A"90)
* CB VB + CD VD (A"91 >
Where CR ;° and C^.° use the concentrations of blood ai Di
and dialysate phases at time zero in the large containers, 
VB is the same as above case. VD is the total closed loop 
volume of dialysate solution which includes the dialysate 
volume of the container, the dialysate volume in the di- 
alyzer and the tubing set volume (see Figure 25). If there 
is no ultrafiltration in a dialysis, then VQ and VD are 
kept constant. In this case, both CB and CD are variables. 
In a dialysis, the dialysate volume of the container is 
always much larger than the dialysate volume in a dialyzer. 
This means CD is close in value to CD;j_. Combining equation 
(A-90 ) and equation (A-q-j) one obtains:
CD i * CD = <CB°VB + CD°V D " CBiVB>/VD <A~ 9?-)
Where CB  ̂ instead of CB is under the same assumption - 
as the above case, the container or human blood volume is 
much larger than the dialyzer blood volume.




1. Countercurrent flow geometry: Substituting
equation (A-92) into equation (A-62) and after rearrange­
ment, one Obtains;
<*CBi _ c (V D+ .B.)
-J—  Bi ( VD ) < VB
o o !b, .°DQB (CDi +cBi Vp' ( VB '
If one sets •
QD-QB
exp[-K0A ( - Q ~ Q - ) ] - 1
D B
Qd ~Qb )_
Q D  Q B  e x p [ - K q A ( q d q q ) ]
f exp[-K^A(QD~QB )1 - 1 
___________QDQB________
Q d “ Q r
^D”^B exp t“KoA ( Q q ") 3DgB
(A-93)
V n + V R  QBQD a -   v 1Vr, B <
Qrj”QRexP [""K0A(— ] - 1
 _______
q d "q rQ^-Q^exp [-K0A 3'D B
o 0 ^D^Bb = (C . +C .  ) ( Vr ).Di Bi VD VB ^
Qd^b
Qd"Qbexp[-K0A(— — ■)] - 1
___________gDgB________
QD“QB
QD"QB exp[~KoA < q d qb  ̂̂
(A-94)
(a -95)
Then equation (A-92) can be represented as following 
simple form:
dC,'Bi~:—  = a Co-; - b dt B1
1 .e.
d(aCBi “ b) = adt
(aCBi “






r  o  CB
d(aCBi”-b)
(aCBi“b) adt (A- 97)
aCBi“b
ln *-aCBi°-b^ at (A-98)
Substituting the value of a and b in equation (A- 93) 
and equation (A-94) into equation (A- 9.8 ) and after re­
arrangement, one obtains:
r VD+VB
ln v D  c B i _ (C .0 .0 V_B )luDi Bi VD >
c • ̂  ^Bl uDl
VD+ VB QBQD
VD VB








1 + VBVD(VBtVp)QDl In
r VD+VB o VB
cBi~(cDi +cBi^lPVH
ln
n . O — p rs ^Bi---- —Di—
^ - B- CBl-(CDi5icBi° !l)
zL >
V VDC ®. -Bl r °.uDl
(A-100)
Substituting equation ^A-9.8 ) into equation (A-57) , 
one has an equation showing the relationship between KQ and
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2. Cocurrent flow geometry: Substituting equation (A- 92)
into equation (A- 75)and rearranging, one has:
^cBi = ,Qb QD \/VB+VP 
dt QB+QD v b v ) < exp[-K0A (D
B
QBQD)] - 1
(Qb QD } (̂ B i % +CDi°VD
V Q D
V V B D
) 1 exp [-KQA (■Qb+ Qp
QBQD
'Bi
■) - 1 (A- 102)
If one sets:
QBQn ^B+^Da = ( ^ v i  ) ( - ^ 7 i) < exp [-KqA (Qb+Qd vbvd 
o
q b +q d
q b q d
) ] - 1 (A-103)




) <! exp [-K0A (-—---)] -1WA- .104)
q bqd
then equation (A-102 jean be represented as equation 




VT VxB. , o B o x 
^Bi ̂ Vp - (CBi° yp + CDi









= A (1+Qb ) 
Qd
In ! + ! _ ) [  VBVD
B V
-1 In [CBi(1+vD)~ (CBi0Vr7Cpi)i
Qb Qd ' lt(vB+vD) 'Bl 'Dl
+ 1 > (A-106)
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Substituting equation (A-105)into equation (57), 









q )(1 + Q^)]  ̂B D
(A- 107)
3. Will mixed dialysate flow geometry: Substituting
equation (A- 92) into equation (A-84) and after rearrange­
ment, one gets:
VB R 0AdCBi QbQd (1+ ̂ ) [exp (- -2_)- 1]
— ;--  = D yBdt K^A CBi
VB ^QD"QB texP(“ QB ) " 1 1
VB KqA^B^D^CBi VD + CDi ) [exp(- ) - 1]
V
KqA
B Qd”Qb Cexp(- ) — 1] 1
(A- .108)
One can follow the same derivation as above two 
cases and sets:
. V
Q Q (1+ r n va =
B, KqA














Then equation (A-108) can be written as equation 
(A-95) After integration and rearrangement, one obtains 
equation (A-111) and gets K0 represented in terms of A,
VD' VB' Qd ' CBi and CDi*
V V D B
° B
K o  -  -  r  l n n-
W V *  ln
V VB





(1+ X®)CBi - (CBi° VB + CDP± VD V- B Vp D
(CBi<5 _ c ~ o T




VB o VB 0
^Bi VD  ̂“ ̂ B i  Vn + ^Di^
C .0 _ r _ .o ^Bi Di
KoAQb [1-exp (- --- )]
Qb
K q AQb
qE texp(- -1 1 -1
(A-.1 12)
Substituting equation (A— 112) into equation C 57) , 
one has an equation showing DB in terms of KQ , A, QB and
APPENDIX B Table of Results
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Table Bl: Blood Membrane Effect on Static Ultrafiltration
Coefficient
Run










1 AlA 2.05 0.90 -56.1%
2 A 1C 2.05 0.74 -63.9%
3 A2A 2.12 1.13 -46.7%
4 A2C 2.02 0.88 t 56.4%
5 A3A 2.63 1.21 -53.9%
6 A3B 2.39 1.12 -53.1%
7 A3C 2.49 1.14 -54.2%
8 A4E 3.10 0.72 -76.8%
9 A4C 2.68 1.30 -51.5%
10 BlA 2.81 1.06 -62.3%
11 BIB 2.56 1.34 -47.6%
12 B3A 3.22 1.05 -67.4%
Average 2.42 1.05 -57.5% ±8.9%
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CO cv cn CN- ĉ ĉ• • • • • •.=)- vn CN- cn vn vn
CM -3- vn cn CN- rH• • • • • •NO CN- VT\ vn
u>i CD
s i < PQ O < pq CJH  7 H rH H -=}■«  X < < < < < <




































































u ep \  »H G 
■H X5









































































































































V i V I V i. V I V I V i V iH c o 0 0 vn ON CM H• • • • • • • •
CM CM ON CO 0 0 cn cn












Eh O  
OS 10
CQ •  (ti © S O
gH  -P 
cd co







b w vn vn rH CO 00 O CM O rH
© © cn CO vn CO On ON cn vr\ ON
■p e-< ON 0 cn 0 CN O O O-
Eh
<





■P vn vn 0 vn rH CM co vn
U TO vn 00 cn ON O rH CN CN











09 Ora ̂  cdS  -P C rH © rH *H Cd O *H -H 
©  <H 




■p to <h ©
OOCn H  O
PQ rHXU


































«< O < 0 < PQ O PQ 0
rH rH CM CM cn cn cn -3- -3 -< < < « : C < < < <

























































a> vs. VS. VS. VS. VS VS vs VS VS
c a cn- O n CN. XA CO CM -=}• CA
£ • • • • • • • • •







O c a x a CA CN. XA CO NO O C^
CM 0 CO NO CM CA -3- O - rH
w CM rH CM CA rH rH rH rH rH
£
B <D P
£  O P










cd o> 0 c v O n Cn. -=* -=}• CO CM XA XA
2  O 0 VO 0 - rH O CM J - CA
£ rH rH rH CA CA rH rH rH rH rH
rH w t t
rH  -P
cd OQ £
£  *H a>
cd co p
>  0) Cm
O  DC <
£ c m a
•H 0 0
£  s CMrH
< D \ «  X
«h  e c a O n O NO rH NO O n XA CN-
09 O £ ON c a CO O -3 - CN- NO rH XA
£ 1— ' CD P • • • • • • • • •
3 p  10 XA CA CA CN. NO XA CN. CO
£  0 Ch  CD




2  0) CXA
•H O  O
rH  O rH rH
rH «H m  X CO O CN C^ CA CM CN- O CA
CO <H ON NO CA CM O n CO O ON
£  Ch £ • • • • • • • • •
CD <D CD P x a XA XA CA NO CN- CN- NO {N-
>  O P  09





£  B -< O < 1 9 < m O PP O
3  £ H rH CM CM C A C A C A -C±
m  2: < < < < < < < <































































^  ^  ^  
tH O  O - 
•  •  •VO CO VO 
rH  CM 




















O (0 CM 00  CM
•rH £ CM CO CO
<D •  •  •







• H \ «H








-P  O T3
H O VO ^  'O
£> O 0  c o  0
pH •  •  •






































O  ON • • •








S  1 # „








H 09 O  
I) 09 \
SPk e
k j- CM CO 
VO CO O  
VO -d- VO
HIp Ek c i CO
OS 0
£ 09 tH
a> 09 •! X
<H cd 09
m s  0 •3 £
£ £ O  *H
rH  3 o s
£ rH  -P
Ek -P cd 09 pq s CO VO co
09 £ * H 0 ON CO rH
CO <D <0 09 £ O  .3 - NO
09 Eh > © a> -p VO
cd O  OS •P  09
S  X3 «H ©
O <  Eh
£  O -P
O  H £
m © l> -P
■p •H 99 G9CO0 £ O k ©  ©a> o) •H 1) £k rH
«H -P «H > X
*H  <H <H 1) (1) -d- NO
W 0) I IS £  • O  rH k j-
O £  £ 00 CO NO
0) O k 09 »H • • •
£ D 09 S rk  CM rk3 u ■J © \





09 09 T3 £
09 cd O  «H CM CO CM
0) £ o s NO ON CO
£ rH ^ V ON CM VO




rk  CM rH
09 £ 0) +3
£ <D -P  09
a> >  C i «h  a>




VO rH  ©
CM *o X>1 C  6 <  pq <
































































































c . 3 Sro U  w o VO rH CVi
U © r a \ <n rH
E-i Op  © c rH rH rH




C t j e
h  a 0 0
|H P o \
(x) to
Ch *H PQ*h O C"- rH0 to 6 ca 0  cn










tH © Eh rH
tH > x O CVI
a> © © CX)
0 PC U rv ov 0
0 3  c • • • '
U  TO *H c*- 00 c*-
© m e
© p  © \









Cd T3 C 0  VO CVI
s O »H ^  ^  CVI
O 6 rv c  ̂ vo
rH r H \ • • •




> c P TO
0  « tH ©
«< EH
©
rH  © ©
T3 fO W)S § <  PQ pq TO3  3 rH rH CV U
PQ sz; PQ PQ PQ ©
>
3 rH CVi O
PC
